Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Dermatology

  Free Subscription


Articles published in J Dermatol

Retrieve available abstracts of 625 articles:
HTML format



Single Articles


    December 2025
  1. MORITA A, Tada Y, Tsunemi Y, Komine M, et al
    Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP).
    J Dermatol. 2025 Dec 30. doi: 10.1111/1346-8138.70122.
    PubMed     Abstract available


  2. HAYAKAWA T, Komai T, Yotsuyanagi T, Shimizu T, et al
    Anaphylaxis to Total Parenteral Nutrition Components Diagnosed by Skin Tests.
    J Dermatol. 2025 Dec 27. doi: 10.1111/1346-8138.70127.
    PubMed     Abstract available


  3. KAWAI T, Hama N, Nakamura R, Yamaguchi S, et al
    A Fatal Case of Enfortumab Vedotin-Caused Cutaneous Adverse Reaction Mimicking Toxic Epidermal Necrolysis With Myelosuppression: Distinct Clinical and Histopathological Features.
    J Dermatol. 2025 Dec 22. doi: 10.1111/1346-8138.70121.
    PubMed    


  4. KYONO K, Tsushima E, Urushidate S, Goto S, et al
    Risk Factors for Microscopic Margin Positivity in Basal Cell Carcinoma Excision With a 2-mm Surgical Margin: A Japanese Retrospective Study.
    J Dermatol. 2025 Dec 21. doi: 10.1111/1346-8138.70118.
    PubMed     Abstract available


  5. FAN X, Liu R, Cao X, Zhang Z, et al
    The Predictive Value of Inflammatory Markers in the Severity and Mortality Risk of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Dermatol. 2025 Dec 19. doi: 10.1111/1346-8138.70116.
    PubMed     Abstract available


  6. KATO H, Tamagawa-Mineoka R, Nakatani E, Yoshimura K, et al
    Safety Evaluation of Fine Bubble Shower Washing for Patients With Atopic Dermatitis: A Double-Blind, Randomized, Prospective Crossover Clinical Trial.
    J Dermatol. 2025 Dec 17. doi: 10.1111/1346-8138.70117.
    PubMed     Abstract available


  7. SAKAI T
    Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management.
    J Dermatol. 2025 Dec 15. doi: 10.1111/1346-8138.70098.
    PubMed     Abstract available


  8. ITO T, Yamamoto T
    A Unique Case of Nodular Cutaneous Lupus Mucinosis With Discoid Lupus Erythematosus-Like Changes in a Patient With Systemic Lupus Erythematosus and Sjogren Syndrome.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70100.
    PubMed    


  9. PARK HS, Kim YH, Kim JY, Choi JW, et al
    Staphylococcus Enrichment in Cutaneous Melanoma.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70110.
    PubMed    


  10. TAKAI T, Kadono T, Fujimoto N, Yoden E, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70104.
    PubMed     Abstract available


  11. KITAO R, Kubo A, Fukumoto T
    Evaluation of Skin Biopsy Techniques for the Diagnosis of Systemic Amyloidosis.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70099.
    PubMed     Abstract available


  12. NOMURA C, Miyagaki T, Oba S, Go K, et al
    Development of Descending Thoracic Aortic Aneurysm in a Psoriasis Patient Under Guselkumab Treatment.
    J Dermatol. 2025 Dec 5. doi: 10.1111/1346-8138.70107.
    PubMed    


  13. ISHIGURO A, Ogata D, Ishiyama K, Oguma J, et al
    Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study.
    J Dermatol. 2025 Dec 5. doi: 10.1111/1346-8138.70097.
    PubMed     Abstract available


  14. NIRENBERG A, Williams R, Steinman H, Anderson S, et al
    The Melanoma Pathology Report: What to Expect and How to Interpret It.
    J Dermatol. 2025 Dec 3. doi: 10.1111/1346-8138.70071.
    PubMed     Abstract available


  15. TANI Y, Makihara S, Morito A, Ohyama M, et al
    Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide.
    J Dermatol. 2025;52:1864-1868.
    PubMed     Abstract available


  16. SUZUKI S, Goto K, Kajimoto K, Adachi K, et al
    Folliculosebaceous Poromas With PAK2 and PAK3 Rearrangements: A Report of Two Cases and Review of the Literature.
    J Dermatol. 2025;52:1902-1905.
    PubMed     Abstract available


  17. KOUMAKI D, Gregoriou S, Evangelou G, Chlouverakis G, et al
    Familial Hidradenitis Suppurativa on the Island of Crete: Distinct Patterns in Clinical Characteristics.
    J Dermatol. 2025;52:1840-1846.
    PubMed     Abstract available


  18. GREGOIRE S, Biba U, Sanchez K, Mesinkovska NA, et al
    The Financial and Time Burden of Alopecia Areata.
    J Dermatol. 2025;52:1892-1896.
    PubMed     Abstract available


  19. IINO K, Takamura S, Fukuda T
    Perinatal Management and Clinical Outcomes of Hereditary Angioedema in Japan: A Case Series and Comprehensive Literature Review.
    J Dermatol. 2025;52:1881-1887.
    PubMed     Abstract available


  20. SESHIMO H, Uchiyama M, Suzuki R, Numata T, et al
    Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series.
    J Dermatol. 2025;52:1874-1880.
    PubMed     Abstract available


  21. MURAI O, Chiba M, Suzuki K, Suwabe K, et al
    An Analysis of IgG Antibody to Periodontopathic Bacteria in Serum of Palmoplantar Pustulosis Patients With Periodontitis.
    J Dermatol. 2025;52:1811-1818.
    PubMed     Abstract available


  22. IKUMI N, Fujita H
    Effectiveness of Brodalumab for Guselkumab-Resistant Pustulotic Arthro-Osteitis in Patients With Palmoplantar Pustulosis: Case Series.
    J Dermatol. 2025;52:1869-1873.
    PubMed     Abstract available


  23. FUKUNAGA A, Kishi Y, Sunaga Y, Arima K, et al
    Prevalence, Comorbidities, and Current Management of Chronic Spontaneous Urticaria in Japan: Retrospective Claims Database Study.
    J Dermatol. 2025;52:1775-1787.
    PubMed     Abstract available


  24. SESHIMO H, Mae K, Ishiguro A, Irisawa R, et al
    Intra-Arterial Infusion Chemotherapy and Radiotherapy for Right Axillary Advanced Basal Cell Carcinoma Treatment.
    J Dermatol. 2025 Dec 1. doi: 10.1111/1346-8138.70095.
    PubMed    


    November 2025
  25. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    PubMed     Abstract available


  26. ENDO M, Yamamoto T
    Lichen Nitidus in a Patient With Systemic Sarcoidosis.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70087.
    PubMed    


  27. JIAO S, Su D, Si S, Zhang N, et al
    Risk Factors for Drug-Induced Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70063.
    PubMed     Abstract available


  28. HIRAISHI A, Kamiya K, Sugihara N, Komine M, et al
    A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70079.
    PubMed    


  29. IRIE K, Yamamoto M, Yamamoto T
    Disseminated Fibrous Papules of the Lip.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70064.
    PubMed    


  30. KATAYAMA S, Nishihara K, Kohri N, Yoshida S, et al
    Successful Treatment of BRAF(V600R)-Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF/MEK Inhibitors.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70080.
    PubMed    


  31. TOYOSHIMA R, Aso S, Matsui H, Fushimi K, et al
    Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database.
    J Dermatol. 2025 Nov 26. doi: 10.1111/1346-8138.70082.
    PubMed     Abstract available


  32. OKAZAKI T, Terui H, Takahashi T, Kobayashi A, et al
    Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70069.
    PubMed     Abstract available


  33. MINAKAWA S, Matsuzaki Y, Hashimoto T, Ishii N, et al
    Lichenoid Drug Eruption due to Telmisartan-Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70068.
    PubMed    


  34. SEISHIMA M, Ikemoto C, Dozen Y, Matsuo M, et al
    Verrucous Cutaneous Candidiasis on the Dorsum of the Finger.
    J Dermatol. 2025 Nov 21. doi: 10.1111/1346-8138.70074.
    PubMed    


  35. HOASHI T, Ishikawa M, Uehara J, Kamitani N, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70050.
    PubMed     Abstract available


  36. AIBA S
    Three Cases of Skin Tags on the Neck Treated With a Novel and Minimally Invasive Approach Using a 2-mm Ring Curette.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70056.
    PubMed     Abstract available


  37. MORITA K, Sagara C, Yoshikawa M, Mikami H, et al
    Amoxicillin-Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70054.
    PubMed    


  38. CHANG YH, Hsueh YY, Hsu CK
    Cutaneous Vegetating Candidiasis in Keratitis-Ichthyosis-Deafness Syndrome.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70049.
    PubMed    


  39. YAMAMOTO-HANADA K, Kawada Y, Okamoto K, Matsukawa M, et al
    Barriers to Accurate Diagnosis of Infantile Atopic Dermatitis: Insights From a Survey of Pediatricians.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70052.
    PubMed     Abstract available


  40. WATABE H, Miyagaki T, Nakajima K, Go K, et al
    Clinical Profile of Psoriasis Patients With Comorbid Fatty Liver and Risk Factors for Advanced Liver Fibrosis in Those With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70047.
    PubMed     Abstract available


  41. TSUKAMOTO T, Iwata Y, Sugiura K
    Successful Treatment of Post-Transplant Generalized Pustular Psoriasis With Apremilast.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70061.
    PubMed    


  42. TAJIRI M, Takeichi T, Teye K, Fukaura R, et al
    Susceptibility to Dermatophytosis in SDR9C7-Nonsyndromic Epidermal Differentiation Disorder: Observation of Cutaneous Inflammation Involving IRF4 and IL-17.
    J Dermatol. 2025 Nov 11. doi: 10.1111/1346-8138.70048.
    PubMed     Abstract available


  43. HASHIMOTO M, Hayakawa R, Fukuyama M, Ohyama M, et al
    Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report.
    J Dermatol. 2025 Nov 11. doi: 10.1111/1346-8138.70051.
    PubMed    


  44. HU B, Liu T, Jiang RL, Chen Q, et al
    Verruciform Xanthoma, Fungal Infection and Cutaneous Squamous Cell Carcinoma in a Patient With Homozygous Mutation in PERP (c.137C>A, p.S46*).
    J Dermatol. 2025 Nov 10. doi: 10.1111/1346-8138.70041.
    PubMed    


  45. HAMADA T, Sugaya M, Sakaida T, Hirai Y, et al
    Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025.
    J Dermatol. 2025 Nov 7. doi: 10.1111/1346-8138.70037.
    PubMed     Abstract available


  46. INOUE S, Hasegawa J, Sou M, Ikari M, et al
    Safe and Effective Use of Nivolumab Monotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma in a 100-Year-Old Patient.
    J Dermatol. 2025 Nov 5. doi: 10.1111/1346-8138.70044.
    PubMed    


  47. HEO JW, Kang HJ, Lim Y
    Experience With Janus Kinase Inhibitors in Acquired Perforating Dermatosis in Older Adults: A Case Series and Review of Literature.
    J Dermatol. 2025;52:1722-1726.
    PubMed     Abstract available


  48. MOCHIZUKI R, Miyazaki R, Nakatani S, Takai T, et al
    Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report.
    J Dermatol. 2025;52:1727-1731.
    PubMed     Abstract available


  49. NAKAMURA M, Nagase K, Kato J, Yasuda M, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Merkel Cell Carcinoma 2025.
    J Dermatol. 2025;52:e954-e967.
    PubMed     Abstract available


  50. CHUNG KB, Sung HJ, Kim EH, Jang H, et al
    Roflumilast for Oral Ulcers in Behcet's Disease and Recurrent Aphthous Stomatitis.
    J Dermatol. 2025;52:1713-1717.
    PubMed     Abstract available


  51. ZHU Y, Yao Y, Shi J, Sun J, et al
    Novel Reported Case of Human Subcutaneous Mycosis Caused by Zasmidium citri-griseum: Diagnosis and Treatment Insights.
    J Dermatol. 2025;52:1736-1740.
    PubMed     Abstract available


  52. SEKINE M, Takahashi T, Okuda S, Hatchome N, et al
    A Case of Taxane-Induced Scleroderma Presenting in a Unilateral Upper Limb and a Literature Review.
    J Dermatol. 2025;52:1746-1749.
    PubMed     Abstract available


  53. ITO Y, Okusa T, Nakada T, Sueki H, et al
    Argyria Induced by Prolonged Ingestion of Silver Ionized Water: A Scanning Transmission Electron Microscopy With Energy-Dispersive X-Ray Analysis Utilizing a Simplified Sample Preparation Method.
    J Dermatol. 2025;52:1741-1745.
    PubMed     Abstract available


  54. AHMED S, Cesarato N, Li Y, Xiong X, et al
    Bi-Allelic DSG1 Splice-Site Variant Identified in a Family With Non-Syndromic Striate Palmoplantar Keratoderma.
    J Dermatol. 2025;52:1709-1712.
    PubMed     Abstract available


  55. AKIN G, Akarsu S, Avci C, Lebe B, et al
    Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid.
    J Dermatol. 2025;52:1691-1697.
    PubMed     Abstract available


  56. NAKAMURA R, Nakamura M, Okuda K, Takagi S, et al
    Quantitative Evaluation of Successful Combination Therapy With Dye Laser and Long-Pulse Alexandrite Laser for Papulopustular Rosacea.
    J Dermatol. 2025;52:1648-1655.
    PubMed     Abstract available


  57. YONEKURA K, Muto I, Takenaka M, Aoi J, et al
    An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.
    J Dermatol. 2025;52:1619-1628.
    PubMed     Abstract available


    October 2025
  58. YAMAZAKI E, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, et al
    Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.
    J Dermatol. 2025 Oct 28. doi: 10.1111/1346-8138.70039.
    PubMed     Abstract available


  59. HEERFORDT IM, Middelboe M, Haerskjold A, Horwitz A, et al
    Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-Up.
    J Dermatol. 2025 Oct 27. doi: 10.1111/1346-8138.70040.
    PubMed     Abstract available


  60. SHIMIZU T, Kamata M, Uratsuji H, Okada Y, et al
    Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform
    J Dermatol. 2025 Oct 25. doi: 10.1111/1346-8138.70031.
    PubMed     Abstract available


  61. GOTO Y, Suzuki T, Honda T
    Dupilumab-Induced Psoriasis-Like Eruption With JAK1-STAT3 Activation Successfully Treated With Upadacitinib.
    J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70035.
    PubMed    


  62. LU YY, Liu YC, Chiu YW, Lin SF, et al
    Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report.
    J Dermatol. 2025 Oct 21. doi: 10.1111/1346-8138.70017.
    PubMed     Abstract available


  63. YAMAMURA Y, Fujii K, Nakashima C, Usui S, et al
    Advanced Verrucous Malignant Melanoma Arising on the Plantar Arch.
    J Dermatol. 2025 Oct 18. doi: 10.1111/1346-8138.70029.
    PubMed    


  64. WATANABE A, Kamata M, Okada Y, Suzuki S, et al
    Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70026.
    PubMed    


  65. HATCHO Y, Kiniwa Y, Katsuie S, Kitamura S, et al
    Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70018.
    PubMed    


  66. WEN W, Yang C, Lin Z
    Multiple Cutaneous Cysts in Nevoid Basal Cell Carcinoma Syndrome.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70025.
    PubMed    



  67. Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance".
    J Dermatol. 2025 Oct 13. doi: 10.1111/1346-8138.17976.
    PubMed    


  68. HAYASHI W, Kinoshita-Ise M, Mizukawa Y, Ohyama M, et al
    Hyperpigmented Drug Eruption Caused by Sanshishi (Gardenia Fruit): A Rare and Potentially Overlooked Skin Manifestation.
    J Dermatol. 2025 Oct 10. doi: 10.1111/1346-8138.70006.
    PubMed    


  69. NAKANO E, Kage Y, Ogata D, Yamazaki N, et al
    Real-World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS-Mutant Melanoma: A Single-Center Retrospective Study in Japan.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.70009.
    PubMed     Abstract available


  70. PENG G, Abudouwanli A, Sun Q, Tan Y, et al
    Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.17975.
    PubMed     Abstract available


  71. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70002.
    PubMed     Abstract available


  72. INOUE S, Shojiguchi N, Murayama Y, Koizumi S, et al
    Recycled Skin Grafting for Reconstruction Following Wide Local Excision of Liposarcoma.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70003.
    PubMed    


  73. DANIEL MB, Lucia MG, de la Maria Sierra GP, Salvador AS, et al
    The Impact of Cutaneous Lupus Erythematosus on Major Life-Changing Decisions: A Cross-Sectional Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70010.
    PubMed     Abstract available


  74. OHTSUKA K, Nakazato S, Hiraki T, Horiuchi M, et al
    PAK2-Fused Porocarcinoma In Situ Presenting With a Cutaneous Horn: A Case Report.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70001.
    PubMed    


  75. AOKI M, Fujii K, Yonekura K, Nishida H, et al
    Efficacy and Safety of Helical Tomotherapy Combined With Paclitaxel in Cutaneous Angiosarcoma.
    J Dermatol. 2025 Oct 3. doi: 10.1111/1346-8138.17981.
    PubMed     Abstract available


  76. MITANI A, Suzuki Y, Yamamura K, Ishii N, et al
    Sudden Death in a Case of Nonbullous Pemphigoid With Immunoglobulin G Anti-120 kDa Linear IgA Bullous Dermatosis Antigen Autoantibodies.
    J Dermatol. 2025 Oct 2. doi: 10.1111/1346-8138.70000.
    PubMed    


  77. KUMA Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, et al
    Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis.
    J Dermatol. 2025;52:1584-1588.
    PubMed     Abstract available


  78. ITAMOTO S, Tu WT, Chang CY, Watanabe M, et al
    Oral Statin Therapy in KRT16- and KRT17-Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita).
    J Dermatol. 2025;52:1608-1611.
    PubMed     Abstract available


  79. NOZAKI H, Honma M, Kishibe M, Fujita Y, et al
    Serum Anti-Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real-World Clinical Practice: A Single-Center Retrospective Study.
    J Dermatol. 2025;52:1598-1602.
    PubMed     Abstract available


  80. CHEN X, Wang Z, Li X, Liu G, et al
    A Missense Variant Within the Helix Termination Motif of KRT71 Causes Autosomal Dominant Woolly Hair/Hypotrichosis in a Chinese Family.
    J Dermatol. 2025;52:1603-1607.
    PubMed     Abstract available


  81. KOGA M, Yoshinaga A, Ehara Y, Tsuge I, et al
    A Retrospective Study of Diffuse Plexiform Neurofibroma With Surgical Intervention in Neurofibromatosis 1.
    J Dermatol. 2025;52:1589-1592.
    PubMed     Abstract available


  82. MORIZANE S, Mukai T, Sunagawa K, Hasui KI, et al
    Biologics and Small-Molecule Therapies in Netherton Syndrome: A Comprehensive Review.
    J Dermatol. 2025;52:1483-1493.
    PubMed     Abstract available


  83. WANG Y, Gao J, Li F, Li L, et al
    Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.
    J Dermatol. 2025;52:1527-1535.
    PubMed     Abstract available


  84. NAIK H, Balwani M, Colwell HH, Mathias SD, et al
    The Burden of Erythropoietic Protoporphyria (EPP): Results From the EPP Life Impact and Genetic Health Trajectory (LIGHT) Study.
    J Dermatol. 2025;52:1576-1583.
    PubMed     Abstract available


  85. ZHANG K, Qiu T, Zhou J, Gong X, et al
    Comparison of Infantile Hemangiomas in Male and Female Infants: A Prospective Study.
    J Dermatol. 2025;52:1555-1560.
    PubMed     Abstract available


  86. HUANG Y, Ke C, Chen M
    Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.
    J Dermatol. 2025;52:1561-1569.
    PubMed     Abstract available


  87. OHYAMA M, Ito T, Amoh Y, Inui S, et al
    Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.
    J Dermatol. 2025;52:e876-e907.
    PubMed     Abstract available


  88. NATSUGA K, Tsuruta D, Takashima S, Tateishi C, et al
    Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa.
    J Dermatol. 2025;52:1494-1502.
    PubMed     Abstract available


    September 2025
  89. MATSUSHITA T, Nakao M, Kudo K, Nishio J, et al
    GAVE in Systemic Sclerosis: A Japanese Cohort Study Highlighting Links to Diffuse Cutaneous Subtype and Anti-RNAPIII Antibodies.
    J Dermatol. 2025 Sep 30. doi: 10.1111/1346-8138.17980.
    PubMed     Abstract available


  90. IRITAS SY, Iritas I
    Ocular Comorbidities in Psoriasis: A Retrospective Study on Dry Eye Syndrome, Keratoconus, and Cataract Development.
    J Dermatol. 2025 Sep 29. doi: 10.1111/1346-8138.17977.
    PubMed     Abstract available


  91. ITO H, Iwata Y, Sugiura M, Arima M, et al
    AID Expression in Vulvar SCC Arising From Lichen Sclerosus et Atrophicus: A Retrospective Study.
    J Dermatol. 2025 Sep 26. doi: 10.1111/1346-8138.17935.
    PubMed     Abstract available


  92. LIU G, Huang T, Gao XJ, Ding RL, et al
    Expression of Co-Inhibitory Molecules on Lymphocytes of Patients With Psoriasis.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17937.
    PubMed     Abstract available



  93. WITHDRAWAL: Autoimmune Progesterone Dermatitis Treated With Dienogest: A Case Report.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17963.
    PubMed     Abstract available


  94. KAMIYA K, Yamaguchi Y, Saeki H, Kodera M, et al
    Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics.
    J Dermatol. 2025 Sep 19. doi: 10.1111/1346-8138.17968.
    PubMed     Abstract available


  95. MUTO Y, Fujihara M, Ogawa Y, Oishi N, et al
    Case of Primary Cutaneous Gamma-Delta T-Cell Lymphoma in Which Brentuximab Vedotin-Based Polychemotherapy Failed to Achieve Durable Remission.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17967.
    PubMed    


  96. TAKAHASHI Y, Hagino T, Saeki H, Fujimoto E, et al
    A 104-Week Real-World Outcome of Bimekizumab Treatment for Psoriasis: Biologic-Naive Versus -Experienced Patients.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17962.
    PubMed     Abstract available


  97. MATSUOKA K, Nakamura Y, Miki H, Nomura T, et al
    Cutaneous Metaplastic Synovial Cyst With Immunohistochemical Studies for Synovial Cell Markers: A Case Report.
    J Dermatol. 2025 Sep 17. doi: 10.1111/1346-8138.17969.
    PubMed    


  98. KATO K, Kato H, Magara T, Morita A, et al
    Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17958.
    PubMed     Abstract available


  99. YAMADA K, Imanishi H, Mine M, Kunimoto H, et al
    Establishment of a Nail Psoriasis Mouse Model by Topical Application of Imiquimod After Nail Removal.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17956.
    PubMed     Abstract available


  100. ZHOU W, Cao Y, Wu C, Zhou K, et al
    Should Be Removed or Taken Biopsy in Early Stage: A Retrospective Study of 953 Cases of Nevus Sebaceous From a Single Center.
    J Dermatol. 2025 Sep 10. doi: 10.1111/1346-8138.17941.
    PubMed     Abstract available



  101. Correction to "A Case of Metastasis of Giant Basal Cell Carcinoma in Oculocutaneous Albinism".
    J Dermatol. 2025 Sep 9. doi: 10.1111/1346-8138.17955.
    PubMed    


  102. TAKAMURA S, Saito S, Sugai S, Shiko Y, et al
    Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17950.
    PubMed     Abstract available


  103. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    PubMed     Abstract available


  104. AHN HK, Oh S, Yoon HS
    Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17949.
    PubMed     Abstract available


  105. ZHANG Y, Cheng C, Xu Z, Yang D, et al
    Indole-3-Lactic Acid Inhibits Keratinocyte Proliferation Through the Aryl Hydrocarbon Receptor in Psoriasis.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17947.
    PubMed     Abstract available


  106. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17938.
    PubMed     Abstract available


  107. KIM DH, Kim YJ, Moon IJ, Lee WJ, et al
    The Association Between Melanoma and Autoimmune Diseases: A Nationwide Population-Based Study in the Republic of Korea.
    J Dermatol. 2025 Sep 4. doi: 10.1111/1346-8138.17945.
    PubMed     Abstract available


  108. KUDO M, Shirato R, Yanagi T, Yamagata W, et al
    Brain Metastasis From Angiosarcoma of the Scalp: Report of Three Cases.
    J Dermatol. 2025;52:1456-1460.
    PubMed     Abstract available


  109. ENDO K, Higaki Y, Cho A, Sugimoto Y, et al
    Disease Impact and Burden of Psoriasis Vulgaris in Visible Body Areas in Japan: A Qualitative Study.
    J Dermatol. 2025;52:1439-1446.
    PubMed     Abstract available


  110. MATSUO M, Asahina R, Tawada C, Tanaka K, et al
    A Case of Local Relapse of Pemphigus Vegetans Detected IL-17A(+) Tissue-Resident Memory T Cells in Lesional Skin.
    J Dermatol. 2025;52:1452-1455.
    PubMed     Abstract available


  111. WANG QX, He HY, Niu YL, Fang S, et al
    Tofacitinib for the Treatment of Primary Localized Cutaneous Amyloidosis.
    J Dermatol. 2025;52:1461-1464.
    PubMed     Abstract available


  112. SUZUKI Y, Tanahashi K, Kobayashi Y, Kinoshita F, et al
    A Cross-Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career.
    J Dermatol. 2025;52:1470-1474.
    PubMed     Abstract available


  113. BRUCKNER AL, Murrell D, Lee LW, Sprecher E, et al
    Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa-Impact of Oleogel-S10.
    J Dermatol. 2025;52:1447-1451.
    PubMed     Abstract available


  114. MATSUSHITA S, Kajihara I, Tsutsui K, Hirai I, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Extramammary Paget Disease 2025.
    J Dermatol. 2025;52:e795-e814.
    PubMed     Abstract available


  115. XUE S, He Y, Pei L, Xu H, et al
    Progress of Biologics and Small Molecule Drugs in the Treatment of Hidradenitis Suppurativa.
    J Dermatol. 2025;52:1337-1350.
    PubMed     Abstract available


  116. MATSUNAGA-NAKASHIMA H, Sawamura S, Myangat TM, Yamamoto T, et al
    Circulating Interleukin-6 and Janus Kinase 2 DNA Copies in Serum Cell-Free DNA Are Elevated in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1430-1438.
    PubMed     Abstract available


  117. KANNO K, Kishibe M, Honma M, Ishida-Yamamoto A, et al
    Pathogenesis of Pseudocheckerboard Pattern in Mechanic's Hands.
    J Dermatol. 2025;52:1418-1423.
    PubMed     Abstract available


  118. MOTEGI SI, Uchida-Yamada M, Shima Y, Shimada T, et al
    The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1382-1394.
    PubMed     Abstract available


  119. OHYAMA M, Irisawa R, Uchiyama M, Mori M, et al
    Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial.
    J Dermatol. 2025;52:1351-1359.
    PubMed     Abstract available


  120. LI POMI F, d'Aloja A, Rottura M, Vaccaro M, et al
    Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.
    J Dermatol. 2025;52:1395-1403.
    PubMed     Abstract available


  121. FUJIWARA H, Irisawa R, Otsuka M, Kako T, et al
    Wound, Pressure Ulcer, and Burn Guidelines (2023)-2: Guidelines for the Diagnosis and Treatment of Pressure Ulcers, Third Edition.
    J Dermatol. 2025;52:e744-e794.
    PubMed     Abstract available


    August 2025
  122. FUJIWARA M, Oda A, Ohtake R, Namiki T, et al
    Hydroxychloroquine-Induced Generalized Pustular Psoriasis Successfully Treated With Secukinumab: A Case Report.
    J Dermatol. 2025 Aug 29. doi: 10.1111/1346-8138.17936.
    PubMed    


  123. MATSUMURA R, Fukuchi K, Honda T
    Multiple Lichen Striatus Accompanied by Cytomegalovirus Infection.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17934.
    PubMed    


  124. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
    PubMed     Abstract available


  125. MARTINS F, Mano F
    Primary Cutaneous Endometriosis of the Umbilicus.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17925.
    PubMed    


  126. AOKI A, Hatamiya Y, Fukamatsu H, Sugiyama S, et al
    Panton-Valentine Leukocidin-Producing Community-Acquired Methicillin-Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17920.
    PubMed     Abstract available


  127. ITO K, Yoshida A, Kishi A, Yamamoto G, et al
    A Case of Necrobiotic Xanthogranuloma Undergone Several Systemic Treatments for Multiple Myeloma: Follow-Up Report of "Necrobiotic Xanthogranuloma With Paraproteinemia Successfully Treated With Melphalan, Prednisolone and Skin Graft".
    J Dermatol. 2025 Aug 21. doi: 10.1111/1346-8138.17922.
    PubMed    


  128. KAWAI K, Uchida Y, Kanekura T
    Prognostic Significance of TBX21 and GATA3 Subtype Classification in Indolent Adult T-Cell Leukemia-Lymphoma With Cutaneous Lesions.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17917.
    PubMed     Abstract available


  129. MATSUI Y, Kato J, Hida T, Horimoto K, et al
    Extended-Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17899.
    PubMed    


  130. MATSUMURA R, Kageyama R, Kageyama H, Shimauchi T, et al
    Ulcerative Sarcoidosis With Cutaneous Sarcoid Granulomatous Vasculitis Successfully Treated by Combination Therapy of Tranilast and Roxithromycin.
    J Dermatol. 2025 Aug 15. doi: 10.1111/1346-8138.17916.
    PubMed    


  131. HE J, Weng T, Bai J, Zhu W, et al
    Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long-Term Treatment Outcomes.
    J Dermatol. 2025 Aug 14. doi: 10.1111/1346-8138.17907.
    PubMed     Abstract available


  132. MATSUMOTO M, Matsudate Y, Kuroo Y, Okazaki H, et al
    A Case of Superimposed Linear Psoriasis That Was Successfully Treated With Secukinumab.
    J Dermatol. 2025 Aug 12. doi: 10.1111/1346-8138.17910.
    PubMed    


  133. GERDES S, Weisenseel P, Gross D, Ostendorf R, et al
    Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.
    J Dermatol. 2025 Aug 9. doi: 10.1111/1346-8138.17866.
    PubMed     Abstract available


  134. KAKURAI M, Akashi T, Moriyama Y
    Spontaneous Regression of Cutaneous Angiosarcoma: A Case Report.
    J Dermatol. 2025 Aug 8. doi: 10.1111/1346-8138.17903.
    PubMed    


  135. HANAMI Y, Nakamura T, Irie K, Mishima H, et al
    Familial Cases of Aicardi-Goutieres Syndrome Presenting With Cutaneous Manifestations of Facial Lipodystrophy and Puffy Digits.
    J Dermatol. 2025 Aug 7. doi: 10.1111/1346-8138.17898.
    PubMed    


  136. KASHANI AN, Yazdanparast T, Amiri F, Kashani MN, et al
    Biophysical and Ultrasonographic Findings of Cutaneous Macular Amyloidosis Lesions in Comparison With Uninvolved Skin.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17824.
    PubMed     Abstract available


  137. NOGAMI K, Nishikawa Y, Mochida K, Terada T, et al
    Maximum Standard Uptake Value of Pre-Therapeutic (18)F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17867.
    PubMed     Abstract available


  138. AZUMA S, Inaba Y, Tateishi C, Hashimoto T, et al
    A Case of Granular C3 Dermatosis With Methemoglobinemia After Administration of Dapsone.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17887.
    PubMed    


  139. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    PubMed    


  140. ZHU K, Lu Z, Cao L, Wu P, et al
    Relationships Between Secukinumab Concentrations, Disease Activity, and IL-17A Levels in Psoriasis: A Cross-Sectional Observational Study.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17893.
    PubMed     Abstract available


  141. KIM MJ, Kim BR, Lee KH, Ju HJ, et al
    Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study.
    J Dermatol. 2025;52:1304-1313.
    PubMed     Abstract available


  142. SAITO N, Kamei K, Gautier G, Kurosky SK, et al
    Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.
    J Dermatol. 2025;52:1255-1262.
    PubMed     Abstract available


  143. HU X, Liu L, Huang Y, Zhang Y, et al
    Novel Molecular Subtyping Revealed Molecular Pathways That Contribute to the Pathogenesis of Rosacea.
    J Dermatol. 2025;52:1285-1296.
    PubMed     Abstract available


  144. HARVEY LF, Kingston P, Kikuchi R, Manasyan A, et al
    Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativa.
    J Dermatol. 2025;52:1263-1273.
    PubMed     Abstract available


  145. YANG MC, Tu WT, Hong YK, Lin YC, et al
    Missense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.
    J Dermatol. 2025;52:1274-1284.
    PubMed     Abstract available


  146. LEE J, Lee JS, Kim JY, Bae JM, et al
    Dermoscopic Features and Their Association With Breslow Thickness of Facial Lentigo Maligna in Koreans: A Multi-Center Retrospective Study.
    J Dermatol. 2025;52:1243-1254.
    PubMed     Abstract available


  147. NAKAYAMA Y, Kiyohara E, Nojima S, Fujimoto M, et al
    Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified With a T-Follicular Helper Phenotype Treated by Rituximab and Low-Dose Prednisolone: A Case Report.
    J Dermatol. 2025 Aug 1. doi: 10.1111/1346-8138.17890.
    PubMed    


    July 2025
  148. SOTO-MORENO A, Olivares-Guerrero M, Lopez-Delgado D, Arias-Santiago S, et al
    PTEN Hamartoma Tumor Syndrome/Cowden Syndrome With Diffuse Sebaceous Gland Hyperplasia: Description of an Atypical Phenotype and a Previously Undescribed Pathogenic Variant.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17880.
    PubMed    


  149. KAMIYA K, Okubo Y, Tada Y, Saeki H, et al
    Questionnaire Survey on the Treatment of Psoriasis Patients Who Achieved Remission With Biologics.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17871.
    PubMed     Abstract available


  150. MATSUZAKI Y, Uehara J, Shibahara T, Suzuki K, et al
    A Case of Metastatic Pigmented Basal Cell Carcinoma With Low Tumor Mutation Burden Responding to Nivolumab.
    J Dermatol. 2025 Jul 24. doi: 10.1111/1346-8138.17881.
    PubMed    


  151. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
    Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
    PubMed     Abstract available


  152. TAKAMURA S, Sugai S, Fukuda T
    Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
    PubMed    


  153. MATSUI Y, Nakano E, Ogata D, Yamazaki N, et al
    Response to Imatinib in Metastatic Esophageal Melanoma Harboring a KIT L576P (Exon 11) Mutation After Treatment Failure of Immune Checkpoint Inhibitors: A Case Report.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17875.
    PubMed    


  154. OIKAWA A, Natsuga K, Watanabe M, Matsukawa T, et al
    Dermoscopic Rosettes in Cutaneous Chronic Graft-Versus-Host Disease.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17870.
    PubMed    


  155. IKOMA T, Amagata Y, Fujii K, Aoki M, et al
    Outcomes of Free Tarsoconjunctival Grafts in Lower Eyelid Reconstruction Following Basal Cell Carcinoma Surgery.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17872.
    PubMed     Abstract available


  156. FUJISAWA Y, Yoshioka Y, Yoshino K, Fujimura T, et al
    Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.
    J Dermatol. 2025 Jul 19. doi: 10.1111/1346-8138.17856.
    PubMed     Abstract available


  157. ROGGO A, Wuest Y, Dummer R, Ramelyte E, et al
    Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell Lymphoma.
    J Dermatol. 2025 Jul 18. doi: 10.1111/1346-8138.17847.
    PubMed     Abstract available


  158. ZHANG J, Ding Y, Wang P, Li L, et al
    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient-Reported Outcomes in a Randomized Trial.
    J Dermatol. 2025 Jul 17. doi: 10.1111/1346-8138.17834.
    PubMed     Abstract available


  159. KIMURA H, Hasegawa A, Kawai T, Ogawa K, et al
    Iatrogenic Kaposi's Sarcoma in a Patient With Chronic Kidney Disease.
    J Dermatol. 2025 Jul 15. doi: 10.1111/1346-8138.17862.
    PubMed    


  160. MATSUDA I, Kato J, Fujie C, Horimoto K, et al
    Acral Melanoma Successfully Treated With Dacarbazine Following Anti-PD-1 Antibody Therapy: A Case Report and Literature Review.
    J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17861.
    PubMed    


  161. KIMURA H, Oginezawa M, Hama N, Watanabe Y, et al
    Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
    J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17860.
    PubMed     Abstract available


  162. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
    Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
    J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
    PubMed     Abstract available


  163. MAIONE V, Venturuzzo A, Bighetti S, Romano C, et al
    NEVIGRAV Study: A Case-Control Analysis on Changes in Melanocytic Nevi During Pregnancy.
    J Dermatol. 2025 Jul 7. doi: 10.1111/1346-8138.17848.
    PubMed     Abstract available


  164. WATABE D, Tsunoda K, Amano H
    Exacerbation of Psoriasis During Treatment With Ofatumumab for Multiple Sclerosis.
    J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17846.
    PubMed    


  165. YOKOI K, Kiyohara E, Fujimoto M
    Multifocal Cutaneous Amyloidosis Mimicking Scleroderma Associated With Primary Cutaneous Marginal Zone Lymphoma.
    J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17850.
    PubMed    


  166. LIM JH, Kang DH, Moon H, Kwon SH, et al
    The Role of T-Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis.
    J Dermatol. 2025;52:1138-1145.
    PubMed     Abstract available


  167. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget's Disease Without Clinical Lymph Node Enlargement.
    J Dermatol. 2025;52:1152-1158.
    PubMed     Abstract available


  168. DOU L, Chen F, He W, Wang J, et al
    Efficacy and Safety of Dupilumab Monotherapy in Patients With Dystrophic Epidermolysis Bullosa: A Retrospective Study of 8 Cases.
    J Dermatol. 2025;52:1159-1165.
    PubMed     Abstract available


    June 2025
  169. FUKUDA A, Kishikawa S, Nakano E, Matsumoto Y, et al
    A Case of Microinvasive Malignant Hidroacanthoma Simplex/Porocarcinoma With Folliculo-Sebaceous Differentiation Only at Lymph Nodes Metastases With Absence of YAP1, PAK1/2/3 Fusions.
    J Dermatol. 2025 Jun 30. doi: 10.1111/1346-8138.17839.
    PubMed    


  170. MISHLAB S, Horowitz N, Bergman R
    Refractory Facial Cutaneous B-Cell Pseudolymphoma in an Atopic Patient Responsive to Dupilumab.
    J Dermatol. 2025 Jun 28. doi: 10.1111/1346-8138.17842.
    PubMed    


  171. MUKAIYAMA R, Yamamoto T
    Subcutaneous Sarcoidosis of the Lower Legs Mimicking Sclerosing Panniculitis in a Rheumatoid Arthritis Patient Under Golimumab Therapy.
    J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17836.
    PubMed    


  172. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
    J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
    PubMed     Abstract available


  173. KITANO T, Horii M, Kudo K, Nishio J, et al
    Disrupted B-Cell Cytokine Homeostasis in Psoriasis: The Impact of Elevated IL-6 and Impaired IL-10 Production.
    J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17804.
    PubMed     Abstract available


  174. HASE T, Fujita Y, Miyamoto K, Shimizu S, et al
    Refractory Post-Zoster Eosinophilic Dermatitis of the Eyelids Successfully Treated With Mycophenolate Mofetil.
    J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17833.
    PubMed     Abstract available


  175. FUKUSHIMA S, Ito T, Asai J, Igaki H, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025.
    J Dermatol. 2025 Jun 13. doi: 10.1111/1346-8138.17740.
    PubMed     Abstract available


  176. KIM MC, Gu MJ, Park YS, Kim JG, et al
    Cutaneous Mature Plasmacytoid Dendritic Cell Proliferation in Primary Myelofibrosis: A Case Report.
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17803.
    PubMed    


  177. YOSHIKAWA S, Kikuchi K, Nozawa K, Nakai Y, et al
    Facial Skin With Conspicuous Enlarged Pores Closely Related to Severity of Facial Acneiform Rash and Therapeutic Effects of EGFR Inhibitors in RAS Wild-Type Metastatic Colorectal Cancer: Ancillary Analysis of FAEISS Study (NCCH1512).
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17813.
    PubMed     Abstract available


  178. KADONO T, Yamamoto M, Aoyama Y, Nakajima K, et al
    CARD14-Associated Papulosquamous Eruption (CAPE) With Ichthyosis and Malignant Melanoma.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17807.
    PubMed    


  179. KAWASE K, Mizutani Y, Inoue M, Akita H, et al
    A Case of Facial-Type Acquired Dermal Melanocytosis on the Lips Successfully Treated With Laser Therapy.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17800.
    PubMed    


  180. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    PubMed    


  181. SHIBA M, Hagino T, Saeki H, Fujimoto E, et al
    The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis.
    J Dermatol. 2025 Jun 2. doi: 10.1111/1346-8138.17812.
    PubMed    


  182. MAEKAWA T, Ito T, Idezuki T, Ota M, et al
    Wound, Pressure Ulcer and Burn Guidelines (2023)-5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group).
    J Dermatol. 2025;52:e481-e528.
    PubMed     Abstract available


  183. ISEI T, Abe M, Ikegami R, Kato H, et al
    Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.
    J Dermatol. 2025;52:e391-e429.
    PubMed     Abstract available


  184. LEE BH, Chung KB, Jang H, Jung YW, et al
    HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behcet's Disease.
    J Dermatol. 2025;52:1001-1007.
    PubMed     Abstract available


  185. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    PubMed     Abstract available


  186. AVALLONE G, Maronese CA, Zussino M, Muratori S, et al
    Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
    J Dermatol. 2025;52:983-1000.
    PubMed     Abstract available


  187. WANG L, Zhang J, Liu Y, Chen Z, et al
    A novel LSS variant leading to hypotrichosis with pseudoainhum.
    J Dermatol. 2025;52:1103-1106.
    PubMed     Abstract available


  188. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    PubMed     Abstract available


  189. OTSUKA A, Tsunemi Y, Nonaka Y
    Impact of shared decision-making in onychomycosis treatment: A cross-sectional study based on the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
    J Dermatol. 2025;52:1031-1038.
    PubMed     Abstract available


  190. NORIMATSU Y, Hamada T, Ito K, Kimura E, et al
    The importance of pseudohyperchloremia for the diagnosis of bromoderma.
    J Dermatol. 2025;52:1078-1082.
    PubMed     Abstract available


  191. LU L, Feng J, Zhang S, He H, et al
    Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review.
    J Dermatol. 2025;52:1008-1014.
    PubMed     Abstract available


    May 2025
  192. SUGAI S, Takamura S, Fukuda T
    Effect of IL-23p19 Inhibitors for Psoriasis With Bullous Pemphigoid: Clinical Insights From Two Cases.
    J Dermatol. 2025 May 30. doi: 10.1111/1346-8138.17805.
    PubMed    


  193. YAMAZAKI K, Tomita K, Masuda Y, Yagi H, et al
    Successful Treatment of Both Cutaneous and Extracutaneous Lesions in Systemic Sarcoidosis With Tranilast.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17765.
    PubMed    


  194. LIU Y, He H, Zhang C, Pan W, et al
    A Wool Hat-A Case of Scalp Psoriasis.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17793.
    PubMed    


  195. NAKANO E, Ogata D, Namikawa K, Yamazaki N, et al
    Real-World Efficacy and Safety of Anti-PD-1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Study in Japan.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17799.
    PubMed     Abstract available


  196. HIRANO S, Ikuno Y, Yamaguchi A, Takahashi T, et al
    Early-Stage Limited Cutaneous Systemic Sclerosis Successfully Treated With Guselkumab: Possibility of Early Intervention in the Pathogenesis.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17796.
    PubMed    


  197. CHARBEL N, Saade D, Maalouly M, Kreidieh F, et al
    Kaposi Sarcoma's Silent Symphony: An Atypical Auricular Presentation.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17797.
    PubMed    


  198. YATSUZUKA K, Muto J, Kohri N, Yoshida S, et al
    Complete Resolution of Residual Psoriasis by Adding Tapinarof Cream to Tildrakizumab: A Case Report.
    J Dermatol. 2025 May 20. doi: 10.1111/1346-8138.17792.
    PubMed    


  199. JIA DD, Xu Y, Ren ZW, Li LQ, et al
    Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.
    J Dermatol. 2025 May 14. doi: 10.1111/1346-8138.17779.
    PubMed     Abstract available


  200. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
    Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17764.
    PubMed     Abstract available


  201. TSUBOI S, Yatsuzuka K, Kohri N, Yoshida S, et al
    Severe Exacerbation of Psoriasis Vulgaris With Topical Imiquimod Therapy: A Case Report.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17782.
    PubMed    


  202. NISHIMURA K, Kimura A, Nakamura A, Takatsuka S, et al
    Impact of Surgical Delay on Prognosis in Patients With Cutaneous Melanoma: A Single-Institution Retrospective Study in Japan.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17773.
    PubMed     Abstract available


  203. IWATA Y, Saito K, Matsushima J, Sugiura K, et al
    Generalized Pustular Psoriasis-Like Eruption Triggered by a G-CSF-Producing Lung Adenocarcinoma.
    J Dermatol. 2025 May 9. doi: 10.1111/1346-8138.17780.
    PubMed    


  204. TAKAYAMA E, Ijuin K, Yoshioka A
    Postherpetic Isotopic Response Manifesting as Granulomatous Dermatitis With Maculopapular Rash, Induced by Immune Checkpoint Inhibitor Use.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17776.
    PubMed    


  205. MURAYAMA Y, Shojiguchi N, Kawasaki T, Inoue S, et al
    Metastatic Cutaneous Apocrine Adenocarcinoma Successfully Treated With Nivolumab.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17777.
    PubMed    


  206. JENG YC, Liao YC, Hong YK, Cheng HC, et al
    Immunoproteomic Response to IL-17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling.
    J Dermatol. 2025 May 6. doi: 10.1111/1346-8138.17772.
    PubMed    


  207. JO SJ, Kim BS, Kim DH, Kim JH, et al
    Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.
    J Dermatol. 2025;52:802-811.
    PubMed     Abstract available


  208. NISHIDA E, Morita A
    The required absolute PASI score to achieve DLQI remission.
    J Dermatol. 2025;52:947-949.
    PubMed     Abstract available


  209. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    PubMed     Abstract available


  210. TANEMURA C, Nunotani M, Kawabata K, Morooka Y, et al
    Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires.
    J Dermatol. 2025;52:812-830.
    PubMed     Abstract available


  211. MATSUO M, Kato H, Kobayashi K, Nagai M, et al
    A case of pseudoangiomatous spindle-cell lipoma with unique MRI manifestations corresponding to distinct histological features.
    J Dermatol. 2025;52:943-946.
    PubMed     Abstract available


  212. KAWAMOTO H, Fujii K, Aoki M, Goto K, et al
    Ultrasound findings of endocrine mucin-producing sweat gland carcinoma mimicking epidermal cysts: A case series and diagnostic challenges.
    J Dermatol. 2025;52:939-942.
    PubMed     Abstract available


  213. HAMAGUCHI Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, et al
    Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
    J Dermatol. 2025;52:860-871.
    PubMed     Abstract available


  214. MATSUO M, Zang X, Im D, Tanaka K, et al
    A case of multiple warty dyskeratomas overexpressing SERCA2 in acantholytic cells.
    J Dermatol. 2025;52:925-928.
    PubMed     Abstract available


  215. XU Y, Yang Y, Zhan W, Zhao J, et al
    Associations of chronic kidney disease with hidradenitis suppurativa: A bidirectional Mendelian randomization study.
    J Dermatol. 2025;52:922-924.
    PubMed     Abstract available


  216. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    PubMed     Abstract available


    April 2025
  217. OKUBO Y, Morita A, Imafuku S, Tada Y, et al
    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In-Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO-4 Trial.
    J Dermatol. 2025 Apr 30. doi: 10.1111/1346-8138.17744.
    PubMed     Abstract available


  218. SHIN BS, Kim M, Suh MK, Lee YB, et al
    Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance Study.
    J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17757.
    PubMed     Abstract available


  219. ASANO Y, Asai J, Ishii T, Iwata Y, et al
    Wound, pressure ulcer, and burn guidelines (2023)-4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers, third edition.
    J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17703.
    PubMed    



  220. Correction to "Clinical Background of Patients With Psoriasiform Skin Lesions due to Tumor Necrosis Factor Antagonist Administration at a Single Center".
    J Dermatol. 2025 Apr 27. doi: 10.1111/1346-8138.17751.
    PubMed    


  221. HACINECIPOGLU F, Celik G, Kartal SP
    Efficacy and Safety of IL-17 and IL-23 Inhibitors in Elderly Patients With Plaque Psoriasis: A Real-World Study.
    J Dermatol. 2025 Apr 26. doi: 10.1111/1346-8138.17755.
    PubMed     Abstract available


  222. TESHIMA R, Saito-Sasaki N, Hara N, Itamura M, et al
    Adult-Onset Langerhans Cell Histiocytosis Mimicking Erosive Pustular Dermatosis of the Scalp.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17762.
    PubMed    


  223. NAKAZATO S, Fujita Y, Anan T
    Microcystic Pseudoglandular Cutaneous Neurofibroma: The First Japanese Case of a Rare Neurofibroma Variant.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17761.
    PubMed    


  224. NAKAJIMA K, Miyagaki T, Okano T, Kadono T, et al
    Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study.
    J Dermatol. 2025 Apr 22. doi: 10.1111/1346-8138.17760.
    PubMed    


  225. TOYOSHIMA R, Shibata S, Kakumoto T, Sato S, et al
    A Case of Parkinsonism Manifested by Exacerbation of Generalized Pustular Psoriasis.
    J Dermatol. 2025 Apr 21. doi: 10.1111/1346-8138.17750.
    PubMed    


  226. LIAO V, Lavin L, Ong MM, Pulitzer MP, et al
    Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17747.
    PubMed     Abstract available


  227. MORTATO E, Marcelli L, Tofani L, Belcastro A, et al
    Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17752.
    PubMed     Abstract available


  228. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    PubMed     Abstract available


  229. IGARI S, Ishikawa M, Ohtsuka M, Yamamoto T, et al
    Multiple Dermatofibromas and Solitary Basal Cell Carcinoma in a Patient With Sarcoidosis.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17735.
    PubMed    


  230. ADHANOM R, Kim C, Strong J, Martinez S, et al
    Cutaneous manifestations of WHIM syndrome.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17733.
    PubMed     Abstract available


  231. KASE Y, Hayashi R, Shimada K, Tsutsui Y, et al
    A Case of Pediatric Cutaneous Sarcoid Vasculitis.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17736.
    PubMed    


  232. FUJISHIGE A, Seko N
    Safety and effectiveness of secukinumab in Japanese patients with generalized pustular psoriasis: A post-marketing surveillance.
    J Dermatol. 2025 Apr 3. doi: 10.1111/1346-8138.17648.
    PubMed     Abstract available


  233. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
    Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
    J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
    PubMed     Abstract available


  234. ZHANG X, Ye Y, Sun W, Sheng Y, et al
    Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial.
    J Dermatol. 2025;52:603-614.
    PubMed     Abstract available


  235. OKUBO Y, Murakami M, Kobayashi S, Tsuji S, et al
    Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: Results from the randomized, phase 3 JumPPP study.
    J Dermatol. 2025;52:593-602.
    PubMed     Abstract available


  236. LI YH, Chuang SH, Yang HJ
    Systematic review and meta-analysis of peripheral blood inflammatory markers in hidradenitis Suppurativa.
    J Dermatol. 2025;52:583-592.
    PubMed     Abstract available


  237. KOGA H, Ishii N, Tsutsumi M, Teye K, et al
    Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases.
    J Dermatol. 2025;52:744-748.
    PubMed     Abstract available


  238. CHEN Y, Li J, Tang Y, Chong S, et al
    Corticosteroids combined with low-dose methotrexate in the treatment of pemphigus vulgaris: A retrospective cohort study.
    J Dermatol. 2025;52:695-700.
    PubMed     Abstract available


  239. TOCHIGI M, Takamiya Y, Ochiai S, Anzawa K, et al
    A case of warts in toe webs due to HPV type 7: Case report and literature review.
    J Dermatol. 2025;52:754-757.
    PubMed     Abstract available


  240. MIYAZAKI K, Kunimoto K, Yasue S, Endo S, et al
    Biomarkers associated with progression of infantile hemangioma: Exploratory study.
    J Dermatol. 2025;52:712-725.
    PubMed     Abstract available


  241. WADA-IRIMADA M, Takahashi T, Sekine M, Okazaki T, et al
    Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.
    J Dermatol. 2025;52:701-711.
    PubMed     Abstract available


  242. CHEN X, Zhang B, Mao X, Wang Y, et al
    Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism.
    J Dermatol. 2025;52:672-681.
    PubMed     Abstract available


  243. SUGAYA M, Nagashima A, Nakamura R, Yano M, et al
    Treatment of facial reactive B-cell rich lymphoid proliferation with dapsone.
    J Dermatol. 2025;52:735-739.
    PubMed     Abstract available


  244. MIURA G, Maeda T, Ujiie H
    Dermoscopic findings in two cases of trichogerminoma.
    J Dermatol. 2025;52:730-734.
    PubMed     Abstract available


  245. MIZAWA M, Makino T, Furukawa F, Shimizu T, et al
    Clinical characterization of mycosis fungoides with abnormal light reactions induced by narrow-band UVB therapy: A review of a single-center experience.
    J Dermatol. 2025;52:726-729.
    PubMed     Abstract available


    March 2025
  246. TADA Y, Sugiura Y, Kamishima M, Takahashi S, et al
    Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan.
    J Dermatol. 2025 Mar 29. doi: 10.1111/1346-8138.17710.
    PubMed     Abstract available


  247. LIU Z, Cheng N, Zheng S, Chen L, et al
    Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti-HMGCR myopathy-associated skin rash: Case series.
    J Dermatol. 2025 Mar 28. doi: 10.1111/1346-8138.17717.
    PubMed     Abstract available


  248. LIU T, Chang J
    Lichen nitidus on the penis.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17719.
    PubMed    


  249. CHO YT, Chou HI, Chan TC, Chen YC, et al
    Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
    PubMed     Abstract available


  250. KIMURA A, Ito T, Abe R, Ujiie H, et al
    Toxic epidermal necrolysis resulting in lip synechiae.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17715.
    PubMed    


  251. AMAGAI R, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, et al
    Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.
    J Dermatol. 2025 Mar 25. doi: 10.1111/1346-8138.17718.
    PubMed     Abstract available


  252. YAMAMOTO K, Okamura K, Saito T, Suzuki T, et al
    Hypopigmented malignant melanoma in a patient with oculocutaneous albinism type 4.
    J Dermatol. 2025 Mar 20. doi: 10.1111/1346-8138.17711.
    PubMed    


  253. MAKI T, Murakami M, Takeichi T, Noda T, et al
    Cutaneous inflammation with upregulated interleukin-36gamma and TNFalpha in a patient with loricrin keratoderma.
    J Dermatol. 2025 Mar 19. doi: 10.1111/1346-8138.17708.
    PubMed    


  254. ONDA M, Hagino T, Saeki H, Fujimoto E, et al
    Long-term maintenance of responses to bimekizumab treatment in moderate-to-severe psoriasis: A real-world comparison of Q4W versus Q8W dosing or bio-naive versus bio-switched patients.
    J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17700.
    PubMed     Abstract available


  255. IGARI S, Yamamoto T
    A unique case of systemic lupus erythematosus presenting with interstitial granulomatous dermatitis at onset and palisaded neutrophilic granulomatous dermatitis at relapse.
    J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17709.
    PubMed    


  256. TORII H, Morita A, Yamamoto C, Dong J, et al
    Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.
    J Dermatol. 2025 Mar 13. doi: 10.1111/1346-8138.17695.
    PubMed     Abstract available


  257. MORITA A, Imafuku S, Tada Y, Okubo Y, et al
    Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials.
    J Dermatol. 2025 Mar 11. doi: 10.1111/1346-8138.17685.
    PubMed     Abstract available


  258. AL-CHAER RN, Folkmann M, Martensson NL, Feldt-Rasmussen U, et al
    Cutaneous manifestations of Fabry disease: A systematic review.
    J Dermatol. 2025 Mar 7. doi: 10.1111/1346-8138.17690.
    PubMed     Abstract available


  259. KARABINOS A, Hrebenar P, Hyblova M, Tomkova E, et al
    A severe ABCC6-induced generalized arterial calcification of infancy overshadowed by the EGFR-associated neonatal inflammatory skin and bowel disease 2 in a Roma girl.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17682.
    PubMed     Abstract available


  260. JINNIN M, Shimokawa T, Kishi A, Hayashi N, et al
    Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17688.
    PubMed     Abstract available


  261. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17672.
    PubMed     Abstract available


  262. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
    Case of allergic contact dermatitis caused by polyurethane elastic cannula.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
    PubMed    


  263. DORFER S, Ablinger M, Wimmer M, Hummel JI, et al
    Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.
    J Dermatol. 2025;52:423-431.
    PubMed     Abstract available


  264. HAUBER B, Whichello C, Mauer J, Law E, et al
    Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.
    J Dermatol. 2025;52:510-514.
    PubMed     Abstract available


  265. SILVER SM, Houghton K, Hitchens A, Ansquer VD, et al
    Real-world assessment of the patient profile, clinical characteristics, treatment patterns, and outcomes associated with erythropoietic and X-linked protoporphyria.
    J Dermatol. 2025;52:416-422.
    PubMed     Abstract available


  266. KUBO A
    History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
    J Dermatol. 2025;52:408-415.
    PubMed     Abstract available


  267. KIM MH
    Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
    J Dermatol. 2025;52:499-504.
    PubMed     Abstract available


  268. LUO H, Chen Y, Li J, Yang Y, et al
    Inflammatory proteins and hidradenitis suppurativa: Insights from genetic correlation and Mendelian randomization.
    J Dermatol. 2025;52:481-492.
    PubMed     Abstract available


  269. DEMIRGIL F, Kugu N, Yilmaz Y
    Traumatic experiences, dissociative symptoms, and alexithymia in patients with alopecia areata.
    J Dermatol. 2025;52:452-459.
    PubMed     Abstract available


  270. KIM BR, Lee KH, Paik K, Kim M, et al
    Comorbid diseases in bullous pemphigoid: A population-based case-control study.
    J Dermatol. 2025;52:460-471.
    PubMed     Abstract available


  271. LI Z, Xie S, Xu X, Chen Z, et al
    Phenotypic and genotypic analysis of SERPINA12-related autosomal recessive palmoplantar keratoderma in southwestern China.
    J Dermatol. 2025;52:545-550.
    PubMed     Abstract available


  272. WANG L, Huang J, Fang L, Zhou Y, et al
    Kodamaea ohmeri infection can be the causative agent of secondary infections of intertrigo: A case study.
    J Dermatol. 2025;52:541-544.
    PubMed     Abstract available


  273. HAYASHI D, Kashiwada-Nakamura K, Noguchi H, Matsumoto T, et al
    Onychomycosis caused by Aspergillus species belonging to section Circumdati.
    J Dermatol. 2025;52:536-540.
    PubMed     Abstract available


  274. CHEN Y, Xie S, Geng J, Li Z, et al
    Biallelic pathogenic variants in the LSS gene cause congenital alopecia-cataract syndrome.
    J Dermatol. 2025;52:531-535.
    PubMed     Abstract available


  275. ULLAH K, Ahmed S, Cesarato N, Xiong X, et al
    Novel pathogenic variants in HR underlie atrichia with papular lesions in a cohort of 10 families.
    J Dermatol. 2025;52:515-519.
    PubMed     Abstract available


  276. GONG Z, Yang S, Ling S, Wang H, et al
    Dermatopathological features and successful treatment with topical antioxidant for ichthyosiform lesions in Mitchell syndrome caused by an ACOX1 variant.
    J Dermatol. 2025;52:445-451.
    PubMed     Abstract available


    February 2025
  277. SEGAWA Y, Takahashi T, Mikami Y, Takahashi T, et al
    A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab.
    J Dermatol. 2025 Feb 26. doi: 10.1111/1346-8138.17686.
    PubMed    


  278. IMAFUKU S, Satoh A, Arima H, Tsuruta N, et al
    Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form-36, and other patient-reported outcomes.
    J Dermatol. 2025 Feb 25. doi: 10.1111/1346-8138.17629.
    PubMed     Abstract available


  279. URATA K, Myangat TM, Kajihara I, Sawamura S, et al
    Increased circulating interleukin 36gamma DNA copies in psoriasis.
    J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17678.
    PubMed    


  280. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
    Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
    J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
    PubMed    


  281. KINOSHITA M, Ogawa Y, Shimada S, Abe R, et al
    Intravenous immunoglobulin inhibits neutrophil extracellular traps in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17675.
    PubMed    


  282. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
    Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
    PubMed     Abstract available


  283. ABE N, Higashi Y, Tateishi C, Kanekura T, et al
    Efficacy of granulocyte and monocyte adsorptive apheresis on skin and joint manifestations of palmoplantar pustulosis with pustulotic arthro-osteitis: A multicentric, prospective, observational study.
    J Dermatol. 2025 Feb 12. doi: 10.1111/1346-8138.17667.
    PubMed     Abstract available


  284. OMASA H, Kakuta R, Terai H, Kawaida M, et al
    A case of epidermal growth factor receptor-mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis.
    J Dermatol. 2025 Feb 11. doi: 10.1111/1346-8138.17666.
    PubMed    


  285. ELRADI M, Hoseiny HAM, Marei A, Boghdadi G, et al
    Intralesional candida antigen versus intralesional varicella zoster vaccine in treatment of molluscum contagiosum: A new promising alternative.
    J Dermatol. 2025 Feb 10. doi: 10.1111/1346-8138.17660.
    PubMed     Abstract available


  286. HORISAKI K, Yoshikawa S, Mori S, Omata W, et al
    Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17613.
    PubMed     Abstract available


  287. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Long-term real-world effectiveness of deucravacitinib in psoriasis: A 52-week prospective study stratified by prior apremilast or biologic therapy.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17665.
    PubMed     Abstract available


  288. MA Y, Chachin M, Hirose T, Nakamura K, et al
    Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
    PubMed     Abstract available


  289. FUJII Y, Takeichi T, Yamashita Y, Okumura T, et al
    Concurrent wild-type transthyretin amyloidosis and psoriasis vulgaris in an elderly man.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17670.
    PubMed    


  290. LV J, Li H, Zheng Y, Lv T, et al
    Treating tislelizumab-induced ulcerative lichenoid drug eruption with baricitinib in a patient with lung cancer.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17662.
    PubMed    


  291. BONCIANI D, Della Bella C, Corra A, Galano A, et al
    The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17645.
    PubMed     Abstract available


  292. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
    Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
    PubMed     Abstract available


  293. MORITA T, Hayama K, Ishii N, Koga H, et al
    Pemphigoid with autoantibodies exclusively reacting with gamma2-subunit of laminin-332 in a patient with psoriasis vulgaris.
    J Dermatol. 2025 Feb 1. doi: 10.1111/1346-8138.17650.
    PubMed    


  294. KAVVALOU E, Krasagakis K, Chlouverakis G, Xekouki P, et al
    Association of statins, gliptins, and antipsychotics with bullous pemphigoid: A case-control study in the Cretan population.
    J Dermatol. 2025;52:291-298.
    PubMed     Abstract available


  295. ITO T, Kukino R, Sarayama Y, Tanioka M, et al
    Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition.
    J Dermatol. 2025;52:e49-e69.
    PubMed     Abstract available


  296. ZENG Q, Lu W, Ye Y, Li M, et al
    Variations in RASA1 and EPHB4 in Chinese patients with capillary malformation-arteriovenous malformation.
    J Dermatol. 2025;52:377-382.
    PubMed     Abstract available


  297. YAMAMOTO T, Yamanaka K, Yamasaki K, Isaji H, et al
    Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: Interim analysis of a post-marketing observational study in Japan.
    J Dermatol. 2025;52:270-280.
    PubMed     Abstract available


  298. YAMAMOTO T
    Erythroderma in the elderly.
    J Dermatol. 2025;52:221-227.
    PubMed     Abstract available


  299. LUO SY, Zhou KY, Wang QX, Feng L, et al
    Clinicopathological features of epithelioid hemangioma of 43 patients with long-term follow-up: A two-center retrospective study.
    J Dermatol. 2025;52:329-336.
    PubMed     Abstract available


  300. ENCARNACION MRN, Kawai R, Kuwabiraki H, Ban N, et al
    Clinical characteristics and outcomes of autoimmune blistering diseases in Japan.
    J Dermatol. 2025;52:299-308.
    PubMed     Abstract available


  301. KATAYAMA S, Izumi K, Ujiie I, Ujiie H, et al
    A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational study.
    J Dermatol. 2025;52:363-366.
    PubMed     Abstract available


  302. NARASAKI M, Kato J, Sato S, Hida T, et al
    Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failure.
    J Dermatol. 2025;52:359-362.
    PubMed     Abstract available


  303. TAN H, Chen X, Chen Y, Ou X, et al
    Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system.
    J Dermatol. 2025;52:309-316.
    PubMed     Abstract available


  304. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
    A case of chronic spontaneous urticaria with wheals lasting for more than a week.
    J Dermatol. 2025;52:344-347.
    PubMed     Abstract available


  305. TOKURA Y, Yunoki M, Kondo S, Otsuka M, et al
    What is "eczema"?
    J Dermatol. 2025;52:192-203.
    PubMed     Abstract available


  306. HIDE M, Kishimoto M, Kotera I, Oh A, et al
    Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
    J Dermatol. 2025;52:256-269.
    PubMed     Abstract available


  307. MUROTA H, Matsumoto M, Arima K, Yoshida T, et al
    Current clinical practice of prurigo nodularis in Japan: A cross-sectional web-survey among dermatologists.
    J Dermatol. 2025;52:348-352.
    PubMed     Abstract available


    January 2025
  308. MORITO K, Kado S, Okada H, Sato A, et al
    Cutaneous squamous carcinoma with pulmonary metastasis with cavity formation successfully treated with nivolumab.
    J Dermatol. 2025 Jan 29. doi: 10.1111/1346-8138.17649.
    PubMed    


  309. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Real-world 52-week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index.
    J Dermatol. 2025 Jan 28. doi: 10.1111/1346-8138.17617.
    PubMed     Abstract available


  310. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
    Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
    PubMed     Abstract available


  311. NISHIHARA K, Fujii K, Aoki M, Hirano Y, et al
    Combination treatment of cultured epithelial autograft and meshed full-thickness skin graft for giant congenital melanocytic nevus.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17529.
    PubMed    


  312. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
    Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
    J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
    PubMed     Abstract available


  313. YONEYAMA M, Hagino T, Saeki H, Fujimoto E, et al
    A predictive factor of oral candidiasis in psoriasis patients treated with bimekizumab: Longer disease duration.
    J Dermatol. 2025 Jan 11. doi: 10.1111/1346-8138.17623.
    PubMed    


  314. HIGUCHI M, Hayashi R, Sato M, Oginezawa M, et al
    A case of toxic epidermal necrolysis like vancomycin-induced linear IgA bullous dermatosis without autoantibody for type VII collagen.
    J Dermatol. 2025 Jan 3. doi: 10.1111/1346-8138.17606.
    PubMed    


  315. AN R, Sun DJ, Lei HX, He AR, et al
    Effect of Epstein-Barr virus on macrophage M2/M1 migration and EphA2 expression in adverse drug reactions.
    J Dermatol. 2025;52:87-96.
    PubMed     Abstract available


  316. YAO QH, Zhi HL, Xia XJ, Liu ZH, et al
    The role of ingrown hairs in persistent kerion of children: A clinical study.
    J Dermatol. 2025;52:35-42.
    PubMed     Abstract available


  317. SUZUKI S, Kamata M, Uchida H, Shimizu T, et al
    Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    J Dermatol. 2025;52:122-131.
    PubMed     Abstract available


  318. FUKUYAMA M, Kinoshita-Ise M, Ohyama M
    Long-term outcomes of intravenous corticosteroid pulse therapy for rapidly progressive alopecia areata: A single-center retrospective analysis of 106 cases and usefulness evaluation of a scoring system originally designed for half-year efficacy predic
    J Dermatol. 2025;52:112-121.
    PubMed     Abstract available


  319. TSUNEMI Y, Otsuka A, Nonaka Y
    Clinical inertia in onychomycosis treatment: results from the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
    J Dermatol. 2025;52:97-111.
    PubMed     Abstract available


  320. SHIMIZU A, Mieko K, Yamaguchi K, Niwa O, et al
    Detection of human papillomavirus in plantar warts and its impact on outcome.
    J Dermatol. 2025;52:175-178.
    PubMed     Abstract available


  321. FUKAURA R, Ato M, Murase C, Miyamoto Y, et al
    Buruli ulcer: An epidemiological update from Japan.
    J Dermatol. 2025;52:3-10.
    PubMed     Abstract available


  322. MOCHIZUKI T, Anzawa K, Bernales-Mendoza AM, Shimizu A, et al
    Case of tinea corporis caused by a terbinafine-sensitive Trichophyton indotineae strain in a Vietnamese worker in Japan.
    J Dermatol. 2025;52:163-166.
    PubMed     Abstract available


  323. HIDA T, Idogawa M, Ishikawa A, Okura M, et al
    A case of familial progressive hyperpigmentation with or without hypopigmentation presenting with hypopigmented striae along the lines of Blaschko.
    J Dermatol. 2025;52:159-162.
    PubMed     Abstract available


  324. TSUNEMI Y, Naka W
    Exploratory study on short-term administration of oral fosravuconazole for tinea pedis.
    J Dermatol. 2025;52:79-86.
    PubMed     Abstract available


  325. WANG H, Wu B, Luo M, Han Y, et al
    Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two-sample Mendelian randomization study of HS with metabolic syndrome.
    J Dermatol. 2025;52:155-158.
    PubMed     Abstract available


  326. KOC HA, Onal BS
    Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross-sectional study.
    J Dermatol. 2025;52:50-55.
    PubMed     Abstract available


  327. MUTO Y, Kinjyo K, Asano Y
    Successful treatment of Darier's disease with apremilast and review of reported cases.
    J Dermatol. 2025;52:138-141.
    PubMed     Abstract available


    December 2024
  328. SAITO-SASAKI N, Aoki M, Fujii K, Yamamura K, et al
    Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma.
    J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17551.
    PubMed     Abstract available


  329. HYOBU R, Ito T, Sakai N, Okura M, et al
    Granular C3 dermatosis with pustular psoriasis-like skin rash.
    J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17604.
    PubMed    


  330. NATSUGA K
    Advanced phasing techniques in congenital skin diseases.
    J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17597.
    PubMed     Abstract available


  331. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Predictive factors for responders to deucravacitinib treatment in patients with psoriasis.
    J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17601.
    PubMed     Abstract available


  332. NISHIO J, Hatta N, Ishii T, Yamamoto K, et al
    CYLD novel splicing mutation in a patient with CYLD cutaneous syndrome with basal cell carcinomas.
    J Dermatol. 2024 Dec 23. doi: 10.1111/1346-8138.17584.
    PubMed    


  333. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
    English version of clinical practice guidelines for the management of atopic dermatitis 2024.
    J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
    PubMed     Abstract available


  334. KAMADA H, Arakawa N, Kato M, Tanji T, et al
    Nemolizumab-induced exacerbation of atopic dermatitis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
    PubMed    


  335. NIKI M, Kubo Y
    A case of Bell palsy during the course of oral TYK2 inhibitor deucravacitinib therapy in psoriasis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17596.
    PubMed    


  336. NAKANO F, Kan T, Ushio Y, Ito H, et al
    A case of malignant melanoma in which adalimumab was effective for steroid-resistant uveitis caused by dabrafenib/trametinib combination therapy.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17594.
    PubMed    


  337. AKIYAMA M
    Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17585.
    PubMed     Abstract available


  338. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
    A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
    PubMed     Abstract available


  339. MORIWAKI Y, Shiraishi M, Shen Q, Du Z, et al
    Experimental method for creating skin with acquired appendage dysfunction.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17579.
    PubMed     Abstract available


  340. MAEDA C, Kido I, Ohara Y, Kase M, et al
    A case of nevoid basal cell carcinoma syndrome with segmentally unilaterally arranged hypertrichosis and circumscribed palmar hypokeratosis histologically presenting as basal cell carcinoma.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17593.
    PubMed    


  341. KATO J, Hida T, Idogawa M, Tokino T, et al
    The genomic landscape of cutaneous squamous cell carcinoma in Japan.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17592.
    PubMed     Abstract available


  342. KIM R, Goto A, Kuroda H, Arichi I, et al
    Linear IgA/IgG bullous dermatosis presenting with refractory oral and esophageal erosions: A case report.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17580.
    PubMed    


  343. YATSUZUKA K, Yoshida S, Miura N, Kohri N, et al
    Effectiveness of guselkumab for avelumab-induced psoriasis in urothelial carcinoma: A case report.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17583.
    PubMed    


  344. HASHIMOTO T, Okuno S
    Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17565.
    PubMed     Abstract available


  345. SONG H, Cheng Y, Wang X, Hong X, et al
    The evaluation of Congo red staining combined with fluorescence microscopy in the diagnosis of primary cutaneous amyloidosis.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17562.
    PubMed     Abstract available


  346. SATOH T
    A new era for understanding and managing common pruritic skin conditions: How to define, diagnose, and treat?
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17574.
    PubMed    


  347. TADA Y, Armstrong AW, Imafuku S, Okubo Y, et al
    Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study.
    J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17570.
    PubMed     Abstract available


  348. TANAKA M, Miyagaki T, Kubo M, Okano T, et al
    Two cases of lymphoma arising in immune deficiency/dysregulation presenting as primary cutaneous anaplastic large cell lymphoma during oral tacrolimus therapy.
    J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17575.
    PubMed    


  349. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Bimekizumab for the treatment of genital, scalp, and nail psoriasis: A 52-week real-world study.
    J Dermatol. 2024 Dec 2. doi: 10.1111/1346-8138.17569.
    PubMed    


  350. PATHAK GN, Agarwal P, Wolfe SM, Patel KH, et al
    Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence.
    J Dermatol. 2024;51:1533-1546.
    PubMed     Abstract available


  351. JALEEL T, Mitchell B, Burge R, Cohee A, et al
    Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.
    J Dermatol. 2024;51:1547-1558.
    PubMed     Abstract available


  352. MATSUO M, Zang X, Miyauchi T, Mizutani Y, et al
    A case of revertant mosaic-like normal-looking spots in a patient with erythroderma with IL36RN and CARD14 heterozygous mutations.
    J Dermatol. 2024;51:1669-1673.
    PubMed     Abstract available


  353. WIEDENMAYER N, Hogrefe K, Mihalceanu S, Winkler JK, et al
    Case report: A novel high-dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy.
    J Dermatol. 2024;51:1665-1668.
    PubMed     Abstract available


  354. TANG KY, Zhang HL, Zhang XY, Jin HZ, et al
    Clinical and laboratory features between anti-TIF1gamma dermatomyositis with and without malignancy: 37 case series and a review.
    J Dermatol. 2024;51:1646-1657.
    PubMed     Abstract available


  355. KIMURA A, Makino T, Kitayama S, Mizawa M, et al
    Immunohistopathological analyses of a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1-3.
    J Dermatol. 2024;51:1711-1715.
    PubMed     Abstract available


  356. KWON O, Wallace M, Messina P, Szende A, et al
    Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real-world chart review in South Korea.
    J Dermatol. 2024;51:1622-1633.
    PubMed     Abstract available


  357. LAN Q, Hua H, Zhou P
    Dystrophic epidermolysis bullosa characterized by mucosal lesions in a Chinese familial case with a novel compound heterozygous mutation of COL7A1.
    J Dermatol. 2024;51:1707-1710.
    PubMed     Abstract available


  358. LAI PT, Tseng HC
    Adopting adalimumab combined surgery in the management of moderate to severe hidradenitis suppurativa: Experience from a single medical center in southern Taiwan.
    J Dermatol. 2024;51:1615-1621.
    PubMed     Abstract available


  359. LI J, Xiao J, Xie X, Deng S, et al
    Individual joints involvement pattern in psoriatic arthritis: A cross-sectional study in China.
    J Dermatol. 2024;51:1607-1614.
    PubMed     Abstract available


  360. CAI L, Yan Y, Li Y, Lin J, et al
    Two cases of eosinophilic pustular folliculitis successfully treated with abrocitinib.
    J Dermatol. 2024;51:1694-1697.
    PubMed     Abstract available


  361. OCHIAI S, Anzawa K, Yamaguchi R, Takamiya Y, et al
    Surface material analysis for human papillomavirus detection in nail Bowen's disease caused by HPV type 58.
    J Dermatol. 2024;51:1690-1693.
    PubMed     Abstract available


    November 2024
  362. FUJISHIGE A, Seko N
    Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance.
    J Dermatol. 2024 Nov 29. doi: 10.1111/1346-8138.17499.
    PubMed     Abstract available


  363. LUO W, Yang X, Ren Y, Tao X, et al
    Cutaneous zosteriform endometrial cancer metastasis.
    J Dermatol. 2024 Nov 27. doi: 10.1111/1346-8138.17536.
    PubMed    



  364. Correction to "Automatic evaluation of nail psoriasis severity index using deep learning algorithm".
    J Dermatol. 2024 Nov 26. doi: 10.1111/1346-8138.17556.
    PubMed    


  365. LIU SW, Wu SE, Chen YH, Soong CY, et al
    Educational video assistance in shared decision-making for psoriasis: Effectiveness and outcomes.
    J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17550.
    PubMed     Abstract available


  366. ALHASSAN E, Christianakis S, DeClerck B, Crew AB, et al
    Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis.
    J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17553.
    PubMed    


  367. SAKAI H, Minami-Hori M, Kuwahara S
    Malignancies in patients with psoriasis during and after biological therapy: A single-center experience.
    J Dermatol. 2024 Nov 16. doi: 10.1111/1346-8138.17554.
    PubMed     Abstract available


  368. ADACHI T, Matsui T, Okata-Karigane U, Takahashi C, et al
    Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17521.
    PubMed     Abstract available


  369. TSAI TF, Tada Y, Kung C, Zhong Y, et al
    Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17448.
    PubMed     Abstract available


  370. SAKIYAMA T, Miyake T, Furuta K, Kabashima K, et al
    A case of toxic epidermal necrolysis with hand-foot syndrome-like rash following tirabrutinib treatment.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17541.
    PubMed    


  371. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study.
    J Dermatol. 2024 Nov 5. doi: 10.1111/1346-8138.17532.
    PubMed     Abstract available


  372. KATSUMI T, Hayashi R, Takei S, Ansai O, et al
    Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis.
    J Dermatol. 2024;51:1461-1469.
    PubMed     Abstract available


  373. SATOH T, Murota H, Aoyama Y, Hashimoto T, et al
    Prurigo chronica multiformis: Expert consensus of the Japanese Dermatological Association.
    J Dermatol. 2024;51:e376-e383.
    PubMed     Abstract available


  374. MORITA A, Okubo Y, Imafuku S, Terui T, et al
    Spesolimab, the first-in-class anti-IL-36R antibody: From bench to clinic.
    J Dermatol. 2024;51:1379-1391.
    PubMed     Abstract available


  375. MESINKOVSKA N, King B, Zhang X, Guttman-Yassky E, et al
    Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
    J Dermatol. 2024;51:1414-1424.
    PubMed     Abstract available


  376. OTA M, Nobeyama Y, Asahina A
    Clinical course of psoriatic arthritis treated with biologics delineated with ultrasonography.
    J Dermatol. 2024;51:1476-1480.
    PubMed     Abstract available


  377. TSUNEMI Y, Otsuka A, Nonaka Y
    Patient-physician perception gaps in setting treatment goals and communication including shared decision making: Results from the survey illuminating dialogues and insights in onychomycosis management (IDIOM survey).
    J Dermatol. 2024;51:1441-1453.
    PubMed     Abstract available


    October 2024
  378. MUKAIYAMA R, Yamamoto T
    Hematologic diseases in patients with cutaneous sarcoidosis.
    J Dermatol. 2024 Oct 28. doi: 10.1111/1346-8138.17525.
    PubMed    


  379. MAEDA S, Imazaki K, Shimizu K, Oishi K, et al
    BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma.
    J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17507.
    PubMed    


  380. HUYNH TN, Yamazaki F, Konrad RJ, Nishikawa Y, et al
    Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis.
    J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17450.
    PubMed     Abstract available


  381. CETINARSLAN T, Aydogdu I, Ermertcan AT
    Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib.
    J Dermatol. 2024 Oct 20. doi: 10.1111/1346-8138.17510.
    PubMed     Abstract available


  382. CHOON SE, Foley PA, Asawanonda P, Fujita H, et al
    Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.
    J Dermatol. 2024 Oct 10. doi: 10.1111/1346-8138.17471.
    PubMed     Abstract available


  383. CHEN Y, Geng J, Xiao Y, Zhou X, et al
    A case of peeling skin syndrome type 1 with novel CDSN gene variation successfully treated with upadacitinib.
    J Dermatol. 2024 Oct 8. doi: 10.1111/1346-8138.17489.
    PubMed     Abstract available


  384. WANG B, Yang J, Wang Y, Liang FM, et al
    Clinical and genetic insights into ABCA12 variants in three Chinese families with ichthyosis: Genotype-phenotype correlation.
    J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17484.
    PubMed     Abstract available


  385. OKAMURA K, Saito T, Arai Y, Suto H, et al
    Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab.
    J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17490.
    PubMed    


  386. UESUGI-UCHIDA S, Fujimoto M, Asano Y, Endo H, et al
    Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.
    J Dermatol. 2024;51:1290-1297.
    PubMed     Abstract available


  387. FUKAURA R, Koizumi H, Akashi N, Imai S, et al
    Buruli ulcer with satellite lesions: A case report from Japan.
    J Dermatol. 2024;51:e360-e362.
    PubMed    


  388. HISADA S, Takeuchi S, Tozawa T, Yamada Y, et al
    Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis.
    J Dermatol. 2024;51:1329-1334.
    PubMed     Abstract available


  389. WANG R, Li R, Wang M
    Unexpected B lymphocytes depletion in a patient with pemphigus vulgaris after a single dose of 50 mg rituximab.
    J Dermatol. 2024;51:e365-e366.
    PubMed    


  390. FUKUYAMA K, Yaguchi T
    Longitudinal melanonychia caused by Cladophialophora boppii: Dermoscopic findings prompting the suspicion of fungal melanonychia.
    J Dermatol. 2024;51:e356-e357.
    PubMed    


  391. ZHENG J
    Regarding the risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
    J Dermatol. 2024;51:e349.
    PubMed    


  392. KUSANO M, Ohashi T, Hiraiwa T, Hashimoto T, et al
    Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita.
    J Dermatol. 2024;51:e333-e334.
    PubMed    


  393. BAI J, Wang S, Chen X, Fang H, et al
    Secukinumab treatment for inflammatory linear verrucous epidermal nevus.
    J Dermatol. 2024;51:e344-e345.
    PubMed    


  394. IRIE K, Takada M, Yamamoto T
    Guselkumab-induced paradoxical exacerbation of extra-palmoplantar lesions in a patient with palmoplantar pustulosis.
    J Dermatol. 2024;51:e342-e343.
    PubMed    


  395. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
    Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'.
    J Dermatol. 2024;51:e370-e371.
    PubMed    


  396. ISHIDA H, Noriki S
    A study of 25 cases tested with the dermatophyte test strip after oral foslavuconazole treatment for tinea unguium.
    J Dermatol. 2024;51:e331-e332.
    PubMed    


  397. BAO HY, Wu XG
    Regarding the dietary habits in adult Japanese patients with vitiligo.
    J Dermatol. 2024;51:e369.
    PubMed    


  398. SUMIOKI A, Saito K, Nishida H, Nishizono A, et al
    Intractable Nocardial mycetoma with possible colonisation by Candida species.
    J Dermatol. 2024;51:1364-1367.
    PubMed     Abstract available


  399. CHO R, Nakajima S, Kaku Y, Tezuka J, et al
    Proteasome inhibitor-associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo-Nishimura syndrome suggest a potential mechanism.
    J Dermatol. 2024;51:1355-1359.
    PubMed     Abstract available


  400. OBARA K, Amoh Y
    A case of AA amyloidosis complicated by proliferating pilomatricoma and a review of the literature.
    J Dermatol. 2024;51:1360-1363.
    PubMed     Abstract available


  401. LUO X, Ruan Z, Liu L
    Causal relationship between metabolic syndrome and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
    J Dermatol. 2024;51:1335-1349.
    PubMed     Abstract available


  402. MINAKAWA S, Matsuzaki Y, Higashino T, Yamada N, et al
    A case of Hailey-Hailey disease with novel ATP2C1 gene variant (c.G925C) showing unusual phenotype.
    J Dermatol. 2024;51:e346-e348.
    PubMed    


  403. JIN S, Yue C, Wang S, Wang P, et al
    Oral abrocitinib in the treatment of refractory dissecting cellulitis of the scalp: A case report.
    J Dermatol. 2024;51:e329-e330.
    PubMed    


    September 2024
  404. YAMAMOTO J, Kambayashi Y, Kuroki S, Asano Y, et al
    Segmental lichen aureus: A case report of zosteriform distribution and severe pain with literature review.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17486.
    PubMed    


  405. SUZUKI S, Hama N, Suzuki R, Yuki A, et al
    Two cases of lichen planus pigmentosus inversus improved by topical tacrolimus application and the avoidance of tight clothing.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17485.
    PubMed    


  406. YAMAMOTO R, Kokubu H, Ikuno Y, Kato M, et al
    Anti-transcription intermediate factor 1-gamma antibody-positive dermatomyositis with refractory skin ulcers and rapid cancer progression.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17482.
    PubMed    


  407. ZHENG B, Zhang Z, Zhou X, Li M, et al
    A mutation in the SREBF1 gene resulting in autosomal-dominant ichthyosis Follicularis, Atrichia, and photophobia syndrome.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17474.
    PubMed    


  408. TSUKAMOTO T, Iwata Y, Ohmiya N, Sugiura K, et al
    A case of familial Mediterranean fever complicated by IgA vasculitis and psoriasis vulgaris.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17470.
    PubMed    


  409. MORIMOTO K, Iwamoto Y, Kanazawa A, Okiyama N, et al
    Simultaneous skin infection of Mycobacterium chelonae and Nocardia thailandica.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17478.
    PubMed    


  410. KAN Y, Horimoto K, Uhara H
    Successful treatment of nail psoriasis by switching to a TYK2 inhibitor after cyclosporine.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17469.
    PubMed    


  411. ITAMOTO S, Miyazawa H, Natsuga K, Yamaga M, et al
    Association between nail psoriasis and obesity: A cross-sectional study at a single institution.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17481.
    PubMed    


  412. YOUN SW, Jo SJ, Park CJ, Kim DH, et al
    Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study.
    J Dermatol. 2024 Sep 27. doi: 10.1111/1346-8138.17446.
    PubMed     Abstract available


  413. KITAYAMA S, Takemoto K, Matsui Y, Makino T, et al
    Remission of intercellular IgG/IgA dermatosis after treatment for cervical cancer.
    J Dermatol. 2024 Sep 24. doi: 10.1111/1346-8138.17473.
    PubMed    


  414. OGAWA Y, Maejima E, Takeichi T, Okamoto T, et al
    Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab.
    J Dermatol. 2024 Sep 20. doi: 10.1111/1346-8138.17464.
    PubMed     Abstract available


  415. FUKUDA A, Ogata D, Oshima Y, Nakano E, et al
    Grade 3 acute kidney injury caused anti-glomerular basement membrane nephritis during immune checkpoint inhibitor treatment for melanoma.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17460.
    PubMed    


  416. KOYAMA A, Li L, Yamamoto T, Taira H, et al
    Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17465.
    PubMed     Abstract available


  417. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    PubMed     Abstract available


  418. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Comparison of efficacy between anti-PD-1 antibody monotherapy and nivolumab plus ipilimumab therapy as first-line immunotherapy for advanced mucosal melanoma in Japanese patients: A single-center, retrospective cohort study.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17445.
    PubMed     Abstract available


  419. LUO Z, Lyu Y, Dong W, Mei Z, et al
    Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17443.
    PubMed    


  420. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
    HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
    PubMed    


  421. OKUSE M, Soekawa M, Itakura A, Kawamura T, et al
    Perspectives of Japanese patients on psoriatic disease burden: Results from "Psoriasis and Beyond," the Global Psoriatic Disease Survey.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17424.
    PubMed     Abstract available


  422. KATO H, Kano S, Yoshimitsu M, Nakagawa Y, et al
    Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17398.
    PubMed     Abstract available


  423. KAWANO N, Nakashima C, Otsuka A
    A case of eczematous paradoxical reactions on the extremities during tildrakizumab treatment for plaque psoriasis.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17441.
    PubMed    


  424. MORITA A, Okubo Y, Imafuku S, Tada Y, et al
    Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17444.
    PubMed     Abstract available


  425. NOBEYAMA Y
    Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis.
    J Dermatol. 2024;51:1143-1156.
    PubMed     Abstract available


  426. MIYACHI H, Sato D, Sakamaki K, Togawa Y, et al
    Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.
    J Dermatol. 2024;51:1172-1179.
    PubMed     Abstract available


  427. KITANO T, Koiwai T, Fujikawa K, Mori S, et al
    Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes.
    J Dermatol. 2024;51:1187-1198.
    PubMed     Abstract available


  428. TORCHIA D
    Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea.
    J Dermatol. 2024;51:1262-1263.
    PubMed    


  429. KATO J, Hida T, Idogawa M, Tokino T, et al
    Genomic profiles of Merkel cell carcinoma in Japan.
    J Dermatol. 2024;51:1259-1261.
    PubMed    


  430. HAMMADI AA, Parmar NV, Farghaly M, Dallal SA, et al
    A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.
    J Dermatol. 2024;51:1157-1171.
    PubMed     Abstract available


  431. HIGUCHI S, Noguchi H, Matsumoto T, Nojo H, et al
    Terbinafine-resistant tinea pedis and tinea unguium in Japanese military personnel.
    J Dermatol. 2024;51:1256-1258.
    PubMed    


  432. FU S, Lu H, Song XZ
    Multiple lupus vulgaris.
    J Dermatol. 2024;51:e289-e290.
    PubMed    


  433. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
    Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
    J Dermatol. 2024;51:1240-1244.
    PubMed     Abstract available


  434. MUTO Y, Fujimura T, Takahashi A, Namikawa K, et al
    Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.
    J Dermatol. 2024;51:1225-1232.
    PubMed     Abstract available


  435. WATANABE T, Watanabe Y, Asai C, Asami M, et al
    Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
    J Dermatol. 2024;51:1208-1215.
    PubMed     Abstract available


  436. YASUNAGA S, Oya K, Ishii Y, Anju K, et al
    Milia-like appearance of vulvar syringoma.
    J Dermatol. 2024;51:e308-e309.
    PubMed    


  437. OYA K, Ishii Y, Takeyama S, Homma Y, et al
    COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.
    J Dermatol. 2024;51:e304-e305.
    PubMed    


  438. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
    Hereditary angioedema with a normal C1 inhibitor in Japanese man.
    J Dermatol. 2024;51:e298-e299.
    PubMed    


  439. SAKIYAMA T, Nakamizo S, Kabashima K
    Comparative analysis of CAII and GCDFP-15 expression in sweat glands unveiling the pathophysiology of acquired idiopathic generalized anhidrosis.
    J Dermatol. 2024;51:e310-e311.
    PubMed    


  440. SONG D, Yi Q, Zhuang K, Yang L, et al
    Unilateral heliotrope rash: A call for recognizing its warning significance in anti-MDA5 antibody-associated dermatomyositis.
    J Dermatol. 2024;51:e319-e320.
    PubMed    


  441. MOLTRASIO C, Tricarico PM, Ronald MR, Lucas B, et al
    Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
    J Dermatol. 2024;51:e324-e325.
    PubMed    


  442. KUROKAMI Y, Yamashita C, Yokoi K, Tonomura K, et al
    A rare case of metastatic extramammary Paget disease developing transfusion-related acute lung injury during chemotherapy.
    J Dermatol. 2024;51:e312-e313.
    PubMed    


  443. TAKAYAMA E, Yoshioka A
    Herpes simplex virus infection with a marginal Nikolsky sign in an immunocompromised patient.
    J Dermatol. 2024;51:e314-e315.
    PubMed    


  444. MASUYUKI R, Sato E, Imafuku S
    A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    J Dermatol. 2024;51:1252-1255.
    PubMed     Abstract available


    August 2024
  445. BERGMANN MS, Loft N, Schwarz CW, Kaur-Knudsen D, et al
    HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment.
    J Dermatol. 2024 Aug 27. doi: 10.1111/1346-8138.17415.
    PubMed     Abstract available


  446. KONDO M, Goto D, Habe K, Yamazoe N, et al
    Changes in skin bacterial flora during the healing process of ulcer caused by self-destruction of lymph nodes due to tuberculous lymphadenitis.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17433.
    PubMed     Abstract available


  447. HAMADA M, Hida T, Idogawa M, Tange S, et al
    Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17434.
    PubMed     Abstract available


  448. HSIEH DM, Shang P, Gao Y, Zhao J, et al
    Successful treatment with spesolimab for generalized pustular psoriasis in an elderly patient with TRPM4 mutation.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17431.
    PubMed    


  449. SAITO H, Omatsu J, Takasaki Y, Osuji Y, et al
    Perianal cutaneous malakoplakia in a patient with anti-MDA5 dermatomyositis.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17430.
    PubMed    


  450. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.
    J Dermatol. 2024 Aug 16. doi: 10.1111/1346-8138.17423.
    PubMed     Abstract available


  451. HIGASHINO T, Konomi M, Kubo A, Horinosono H, et al
    Coincidence of acral peeling skin syndrome and Nagashima-type palmoplantar keratosis in a Japanese pedigree with acral skin peeling.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17422.
    PubMed     Abstract available


  452. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17427.
    PubMed     Abstract available


  453. MATSUO M, Niwa H, Iwata H
    A case of metastasis of giant basal cell carcinoma in oculocutaneous albinism.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17425.
    PubMed    


  454. TAKAHASHI H, Morimoto H, Sugimura Y, Honda T, et al
    Primary localized cutaneous nodular amyloidosis of the scalp arising from folliculitis decalvans.
    J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17418.
    PubMed    


  455. MINAKAWA F, Yamamoto T, Aoyama Y
    Simultaneous distinct cutaneous fungal infections with chromoblastomycosis due to Exophiala xenobiotica and hyalohyphomycosis due to Scedosporium apiospermum in a patient with severe cellular immunodeficiency.
    J Dermatol. 2024 Aug 5. doi: 10.1111/1346-8138.17412.
    PubMed     Abstract available


  456. NODA T, Takeichi T, Tanahashi K, Muro Y, et al
    A case of pachyonychia congenita with a hotspot variant at Arg127 in KRT16: Disease severity assessment using AlphaMissense technology.
    J Dermatol. 2024;51:1134-1136.
    PubMed    


  457. KLUIJVER LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, et al
    Quality of life in children with erythropoietic protoporphyria: a case-control study.
    J Dermatol. 2024;51:1068-1078.
    PubMed     Abstract available


  458. MATSUDA Y, Miyake T, Toda H, Tachibana K, et al
    The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis.
    J Dermatol. 2024;51:1108-1112.
    PubMed     Abstract available


  459. SHIN SH, Kim JY, Kim SC, Kim JH, et al
    Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus.
    J Dermatol. 2024;51:1104-1107.
    PubMed     Abstract available


  460. OKUBO A, Hanada M, Kodama S, Taniguchi N, et al
    Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patients.
    J Dermatol. 2024;51:1091-1097.
    PubMed     Abstract available


  461. INOUE T, Watabe D, Furukawa M, Goto M, et al
    Prevalence and risk factors for onychomycosis in acute care dermatology wards.
    J Dermatol. 2024;51:1079-1082.
    PubMed     Abstract available


  462. NARUSE S, Takashima S, Fujita Y, Kataoka H, et al
    Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody.
    J Dermatol. 2024;51:e268-e269.
    PubMed    


  463. LEE KH, Jeong JH, Park CJ, Kim YS, et al
    Resolution of extensive plantar verruca vulgaris but not facial verruca plana following nonavalent human papillomavirus vaccine: A case report and literature review.
    J Dermatol. 2024;51:e279-e281.
    PubMed    


  464. FUKAURA R, Takeichi T, Noda T, Seishima M, et al
    A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability.
    J Dermatol. 2024;51:e274-e276.
    PubMed    


  465. YANO D, Ohsawa I, Suga Y, Mitsuishi T, et al
    Unusual clinical presentation of extragenital condyloma acuminatum.
    J Dermatol. 2024;51:e277-e278.
    PubMed    


  466. IKUMI N, Fujita H
    Long-term control of spondylitis by short-term ixekizumab treatment in a patient with palmoplantar pustulosis.
    J Dermatol. 2024;51:e255-e256.
    PubMed    


  467. NORIMATSU Y, Saku A, Kawashima H, Minagawa T, et al
    Polyarteritis nodosa with splenic rupture and multiple cerebral infarctions.
    J Dermatol. 2024;51:e259-e260.
    PubMed    


  468. MATSUZAKI E, Kajihara I, Tomiguchi M, Kimura T, et al
    Effectiveness of trabectedin for radiation-induced angiosarcoma of the breast refractory to several anticancer drugs.
    J Dermatol. 2024;51:e257-e258.
    PubMed    


  469. MISAKI M, Takeichi T, Omi M, Ito Y, et al
    Localized epidermolysis bullosa simplex caused by a previously unreported substitution in the linker 12 domain of keratin 14.
    J Dermatol. 2024;51:e264-e265.
    PubMed    


  470. YANG XS, Wang TT, Ding YX, Chen YH, et al
    Concentrated growth factor therapy as cosmetic treatment in discoid lupus erythematosus.
    J Dermatol. 2024;51:1125-1128.
    PubMed     Abstract available


  471. HUA H, Li M, Zhai X, Zhou S, et al
    Sleep quality correlates with effectiveness of ultrapulse fractional CO(2) laser in the treatment of facial atrophic acne scars.
    J Dermatol. 2024;51:1120-1124.
    PubMed     Abstract available


  472. ZHAO A, Wang Y, Jia N, Lu F, et al
    Mosaic GJB2 mutations in widespread porokeratotic adnexal ostial nevus: Report of two patients.
    J Dermatol. 2024;51:1129-1133.
    PubMed     Abstract available


  473. GUO Z, Guo M, Gui G, Liu Y, et al
    Emergence of verrucous psoriasis post-secukinumab therapy.
    J Dermatol. 2024 Aug 1. doi: 10.1111/1346-8138.17402.
    PubMed    


    July 2024
  474. IM D, Ueda K, Niwa H, Tanaka K, et al
    A case of bullous pemphigoid associated with psoriasis showing no tissue-bound immunoglobulin G on the inflamed skin.
    J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17408.
    PubMed    


  475. VAN DER VELDEN JJAJ, van Gisbergen MW, Kamps MAF, Janssen R, et al
    Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.
    J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17395.
    PubMed     Abstract available


  476. BUENO-MOLINA RC, Hernandez-Rodriguez JC, Zulueta-Dorado T, Pereyra-Rodriguez JJ, et al
    Pyrin-associated autoinflammation with neutrophilic dermatosis: A case report.
    J Dermatol. 2024 Jul 28. doi: 10.1111/1346-8138.17390.
    PubMed     Abstract available


  477. ZUO Y, Zhang Y, Qu Z, Wang B, et al
    Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes.
    J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17366.
    PubMed     Abstract available


  478. OKAZAKI T, Takahashi T, Asano Y
    Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute-on-chronic pancreatitis: A case report.
    J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17406.
    PubMed    


  479. CHEN J, Luo Y, Duan Y, Wang L, et al
    A double-blind pilot study of oral baricitinib in adult patients with lupus erythematosus panniculitis.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17354.
    PubMed     Abstract available


  480. OHATA C, Anezaki H, Yanase T, Katayama E, et al
    Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17385.
    PubMed     Abstract available


  481. WINKLER M, Albrecht JD, Sauer C, Kordass T, et al
    Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17339.
    PubMed     Abstract available


  482. MIURA G, Watanabe M, Kosumi H, Nohara T, et al
    Blaschkoid granulomatous pigmented purpuric dermatosis in childhood.
    J Dermatol. 2024 Jul 17. doi: 10.1111/1346-8138.17379.
    PubMed    


  483. SEKI T, Makino T, Hayashi M, Kitayama S, et al
    Repigmentation from the epidermis around the acrosyringium in vitiligo universalis.
    J Dermatol. 2024 Jul 15. doi: 10.1111/1346-8138.17388.
    PubMed    


  484. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
    Author reply to does dermatophytosis of the feet cause acral melanoma?
    J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17377.
    PubMed    



  485. Correction to "Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies".
    J Dermatol. 2024 Jul 8. doi: 10.1111/1346-8138.17362.
    PubMed    


  486. AL-BUSANI H, Namiki T, Yokoyama K, Miura K, et al
    A combination of PET-CT and thallium-201 scintigraphy has a diagnostic potential in detecting systemic sarcoidosis in a patient with malignant melanoma.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17372.
    PubMed    


  487. INOZUME T, Fukushima S, Fukuda T, Harada K, et al
    Does dermatophytosis of the feet cause acral melanoma?
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17378.
    PubMed    


  488. KWAN YH, Oh CC
    Brown pigmentation on skin post intravenous ferric carboxymaltose.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17376.
    PubMed    


  489. JINSHAN Z, Yong Q, Fangqi C, Juanmei C, et al
    The role of TNF-alpha as a potential marker for acute cutaneous lupus erythematosus in patients with systemic lupus erythematosus.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17355.
    PubMed     Abstract available


  490. ARRIETA VINAIXA A, Alonso Usero V, Moro R
    Extensive cornified Darier's disease: A rare presentation.
    J Dermatol. 2024;51:e225-e226.
    PubMed    


  491. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
    Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study.
    J Dermatol. 2024;51:950-963.
    PubMed     Abstract available


  492. RAN X, Ran Y
    The horizontal and vertical pathological perspectives of black dot ringworm hair.
    J Dermatol. 2024;51:e223-e224.
    PubMed    


  493. RIINA L, Jari J, Laura H, Suvi-Paivikki S, et al
    Erythema nodosum in northern Finland between 1996 and 2019: A register-based study.
    J Dermatol. 2024;51:1017-1021.
    PubMed     Abstract available


  494. YOKOI S, Iwata Y, Sugiura K
    A retrospective clinicopathological study of erythema nodosum.
    J Dermatol. 2024;51:985-990.
    PubMed     Abstract available


  495. KIKUCHI N, Yamamoto T
    Serum cytokine profiles in a case of post-cesarean pyoderma gangrenosum.
    J Dermatol. 2024;51:e245-e246.
    PubMed    


  496. NIIMURA Y, Kamata M, Ishikawa T, Nagata M, et al
    308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
    J Dermatol. 2024;51:977-984.
    PubMed     Abstract available


  497. NAKA W, Tsunemi Y
    Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial.
    J Dermatol. 2024;51:964-972.
    PubMed     Abstract available


  498. BAX C, Aghdasi C, Fiorentino D
    Novel therapeutic targets in dermatomyositis.
    J Dermatol. 2024;51:920-926.
    PubMed     Abstract available


  499. OKAZAKI T, Takahashi T, Asano Y
    Eosinophilic annular erythema successfully treated with dupilumab: A case report.
    J Dermatol. 2024;51:e249-e250.
    PubMed    


  500. FUKASAWA T, Yoshizaki-Ogawa A, Sato S, Yoshizaki A, et al
    The role of B cells in systemic sclerosis.
    J Dermatol. 2024;51:904-913.
    PubMed     Abstract available


  501. KOGA H, Teye K, Hamada T, Katsumi T, et al
    A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation.
    J Dermatol. 2024;51:e231-e232.
    PubMed    


  502. MATSUMOTO C, Terada N, Harada Y, Takahashi M, et al
    Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.
    J Dermatol. 2024;51:e233-e234.
    PubMed    


  503. ZHANG X, Xiao Y, Li X, Wang J, et al
    Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.
    J Dermatol. 2024;51:1026-1030.
    PubMed     Abstract available


  504. LIU Y, Chen L, Xie Y, Deng S, et al
    A case of Bacille Calmette-Guerin-induced generalized lupus vulgaris in a Mendelian susceptibility to mycobacterial disease patient with a novel STAT1 variant.
    J Dermatol. 2024;51:e229-e230.
    PubMed    


  505. SOMPOCHPRUETIKUL K, Khongcharoensombat T, Chongpison Y, Rittirongwattana W, et al
    Whey protein and male acne: A double-blind, randomized controlled trial.
    J Dermatol. 2024;51:1022-1025.
    PubMed     Abstract available


  506. PIZZICHETTA MA, Corsetti P, Stanganelli I, Ghigliotti G, et al
    More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma.
    J Dermatol. 2024;51:999-1003.
    PubMed     Abstract available


    June 2024
  507. LIU L, He Y, Hu Q, Sun K, et al
    Vulvar lichen sclerosus in girls and adult females: A single-center retrospective study of 744 patients in China.
    J Dermatol. 2024 Jun 28. doi: 10.1111/1346-8138.17352.
    PubMed     Abstract available


  508. DANCE B, Dardare A, Fleming J, Siow SF, et al
    The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
    J Dermatol. 2024 Jun 24. doi: 10.1111/1346-8138.17276.
    PubMed     Abstract available


  509. KIRATIKANON S, Maneenut A, Noppakun N, Kumtornrut C, et al
    Effects of spironolactone on skin biophysical properties in women with acne treated with oral spironolactone.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17333.
    PubMed     Abstract available


  510. FAN H, Yan L, Tan Y, Feng J, et al
    Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17285.
    PubMed    


  511. LIN F, Wang Y, Zheng Y, Hong W, et al
    Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17320.
    PubMed     Abstract available


  512. TSAI YY, Chen YJ, Chang LS, Wu CC, et al
    Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted alpha-toxin on filaggrin expression.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17326.
    PubMed     Abstract available


  513. ITO K, Akatsuka T, Morimura S, Hamada T, et al
    Primary cutaneous follicle center lymphoma localized on the back for 22 years.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17345.
    PubMed    


  514. MITSUYAMA S, Higuchi T, Nabekura T, Wakamatsu K, et al
    Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17342.
    PubMed    


  515. HA GU, Kim JH, Ha DL, Lee H, et al
    Ultrasonographic evaluation of nail matrix topography for preservative nail surgery of nail unit melanoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17340.
    PubMed     Abstract available


  516. SUZUKI S, Kamata M, Ito M, Watanabe A, et al
    Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17337.
    PubMed    


  517. HIRAI Y, Sakurai J, Yoshida S, Kikuchi T, et al
    Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17324.
    PubMed     Abstract available


  518. KAWAMOTO M, Kawakami Y, Hirai Y, Kubota S, et al
    Disseminated Lomentospora prolificans infection presenting with multiple cutaneous lesions in an immunocompromised host: A case report and literature review.
    J Dermatol. 2024 Jun 12. doi: 10.1111/1346-8138.17322.
    PubMed    


  519. KOMATSU S, Kamiya T, Kato J, Uhara H, et al
    A small melanoma of the finger characterized predominantly by nest proliferation and a parallel furrow pattern.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17332.
    PubMed    


  520. HEERFORDT IM, Framke E, Windfeld-Mathiasen J, Mogensen M, et al
    Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17338.
    PubMed     Abstract available


  521. PAIK K, Kim BR, Youn SW
    Automatic evaluation of Nail Psoriasis Severity Index using deep learning algorithm.
    J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17313.
    PubMed     Abstract available


  522. WATABE D, Amano H
    Development of psoriasis during obinutuzumab treatment in a patient with follicular lymphoma.
    J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17317.
    PubMed    


  523. YAMASHITA T, Shimizuhira C, Hiwa R, Fukuoka M, et al
    A case of generalized pustular psoriasis following discontinuation of apremilast.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17314.
    PubMed    


  524. KUBA-FUYUNO Y, Kido-Nakahara M, Tsuji G, Sakai S, et al
    Proposal of a cutaneous lupus erythematosus-like keratinocyte model in vitro under local conditions using interferon-alpha and Poly I:C and its use in examining the therapeutic effects of tyrosine kinase 2 inhibitor.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17318.
    PubMed    


  525. DA ROSA GP, Vide J, Azevedo F, Mota A, et al
    Skin hyperpigmentation heralding an ectopic adrenocorticotropic hormone production.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17323.
    PubMed    


  526. PARADISI A, Ciobotariu I, Quattrini L, Ricci F, et al
    Linear atrophoderma of Moulin.
    J Dermatol. 2024;51:e183-e184.
    PubMed    


  527. MATSUDA KM, Sugimoto E, Ako Y, Kitamura M, et al
    Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin admini
    J Dermatol. 2024;51:741-751.
    PubMed     Abstract available


  528. LIANG S, Fang Y, Zhao Z, Wang B, et al
    Hematological parameters as diagnostic biomarkers for patients with rosacea.
    J Dermatol. 2024;51:791-798.
    PubMed     Abstract available


  529. IWASAKI T, Shimoda-Komatsu Y, Ida Y, Shimoyamada H, et al
    A case of chromomycosis due to Cladosporium halotolerans: Successful identification of previously unreported pathogen with a molecular approach.
    J Dermatol. 2024;51:e220-e222.
    PubMed    


  530. SCHAFER F, Beltran C, Miranda R, Villaseca MA, et al
    Anetoderma: Unusual clinical presentation of granuloma annulare.
    J Dermatol. 2024;51:e209-e210.
    PubMed    


  531. ASAI J, Maruyama A, Katoh N
    Lupus miliaris disseminatus faciei successfully treated with topical adapalene and benzoyl peroxide.
    J Dermatol. 2024;51:e214-e215.
    PubMed    


  532. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
    J Dermatol. 2024;51:873-877.
    PubMed     Abstract available


  533. WADA S, Nakano E, Nakajima M, Kishikawa S, et al
    Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly.
    J Dermatol. 2024;51:e196-e197.
    PubMed    


  534. KOIZUMI S, Doi R, Aitake U, Lei X, et al
    Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
    J Dermatol. 2024;51:e203-e204.
    PubMed    


  535. NAKATANI K, Noborio R, Nomura Y, Ueki Y, et al
    A case of anti-laminin gamma1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
    J Dermatol. 2024;51:869-872.
    PubMed     Abstract available


  536. TAKAHAGI S, Matsuo Y, Kanamoto M, Kawamoto I, et al
    Pemphigus vulgaris relapsed with serological shift from single-positive desmoglein-3 antibodies to single-positive desmoglein-1 antibodies.
    J Dermatol. 2024;51:e198-e200.
    PubMed    


  537. OMI M, Takeichi T, Ito Y, Yoshikawa T, et al
    Two patients with Hailey-Hailey disease with novel pathogenic ATP2C1 variants suggesting possible genotype/phenotype correlations.
    J Dermatol. 2024;51:e185-e187.
    PubMed    


    May 2024
  538. TERAOKA M, Yonekura S, Takegami T, Murata T, et al
    Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17311.
    PubMed    


  539. TAKESHIMA R, Kamata M, Suzuki S, Ito M, et al
    Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17277.
    PubMed     Abstract available


  540. SUGIURA S, Yamamoto B, Fujimoto N
    A case of erosive pustular dermatosis of the scalp with ulcerative colitis successfully treated with upadacitinib.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17282.
    PubMed    


  541. PAPA V, Li Pomi F, Borgia F, Vaccaro M, et al
    Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.
    J Dermatol. 2024 May 22. doi: 10.1111/1346-8138.17278.
    PubMed     Abstract available


  542. AKATSUKA T, Matsuoka A, Norimatsu Y, Morimura S, et al
    A case of IgG4-related disease presenting as skin tumors in the bilateral cheeks.
    J Dermatol. 2024 May 17. doi: 10.1111/1346-8138.17271.
    PubMed    


  543. TADA Y, Sugiura Y, Kamishima M, Tanaka Y, et al
    Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
    J Dermatol. 2024 May 15. doi: 10.1111/1346-8138.17255.
    PubMed     Abstract available


  544. NAKANO E, Takahashi A, Ogata D, Namikawa K, et al
    Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan.
    J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17263.
    PubMed     Abstract available


  545. JO SJ, Park CJ, Bang CH, Jeong KH, et al
    Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea.
    J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17253.
    PubMed     Abstract available


  546. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
    Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
    PubMed     Abstract available


  547. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
    High prevalence of dermatophytosis of the feet in acral melanoma of the foot.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17256.
    PubMed     Abstract available


  548. AITAKE U, Ishizuki S, Lei X, Izumi T, et al
    Long-term control of giant primary acral melanoma without amputation surgery.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17267.
    PubMed    


  549. TAKAYAMA E, Kuwahara S, Yoshioka A, Tateishi C, et al
    Granular C3 dermatosis-A report of two cases and a mini-review of literature.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17257.
    PubMed     Abstract available


  550. WADA M, Ota S, Sugawara-Mikami M, Yaguchi T, et al
    Primary cutaneous nocardiosis caused by Nocardia beijingensis in an immunocompetent host in Japan.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17266.
    PubMed    


  551. WATANABE K, Otsuki M, Ohara Y, Wakasa T, et al
    White patches due to complete loss of melanocytes in vulvar lichen sclerosis: Concomitant presence of vitiligo or not?
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17265.
    PubMed    


  552. SHI Y, Wan S, Song X
    Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    J Dermatol. 2024;51:621-631.
    PubMed     Abstract available


  553. GRAM SB, Brusgaard K, Bygum A, Christensen AH, et al
    Plantar keratoderma and curly hair as a diagnostic clue of cardiomyopathy risk.
    J Dermatol. 2024;51:e143-e144.
    PubMed    


  554. IM D, Ueda K, Niwa H, Tanaka K, et al
    Low pH condition impairs BP-IgG binding to the basement membrane zone.
    J Dermatol. 2024;51:643-648.
    PubMed     Abstract available


  555. FUSHIDA N, Horii M, Fujii K, Mizumaki K, et al
    Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective study.
    J Dermatol. 2024;51:704-713.
    PubMed     Abstract available


  556. TAO S, Cao P, Jin M, Suo P, et al
    Integrated analysis of long non-coding RNAs and mRNAs associated with condyloma acuminatum.
    J Dermatol. 2024;51:671-683.
    PubMed     Abstract available


  557. CHOI S, Kwon SH, Sim WY, Lew BL, et al
    Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
    J Dermatol. 2024;51:684-690.
    PubMed     Abstract available


  558. PIZZICHETTA MA, Polesel J, Perrot JL, Rubegni P, et al
    The combination of dermoscopy and reflectance confocal microscopy increases the diagnostic confidence of amelanotic/hypomelanotic lentigo maligna.
    J Dermatol. 2024;51:714-718.
    PubMed     Abstract available


  559. MIYAMOTO J, Kawashima Y, Hayakawa M, Fusumae T, et al
    Successful treatment of onychomatricoma with minimally invasive surgical procedures based on its pathogenesis: A case report.
    J Dermatol. 2024;51:719-721.
    PubMed     Abstract available


  560. PASCOLINI G, Di Zenzo G, Morani P, Didona B, et al
    Ectoderm-derived findings in Ayme-Gripp syndrome.
    J Dermatol. 2024;51:e162-e163.
    PubMed    


  561. SHIMOMURA-ISHIHARA M, Takeichi T, Noda T, Koizumi H, et al
    Natal teeth, hypoplasia of the first toe, and growth retardation in a patient with severe epidermolysis bullosa simplex.
    J Dermatol. 2024;51:e175-e177.
    PubMed    


  562. OGURA Y, Kondo S, Suzuki T, Otsuka M, et al
    DiGeorge syndrome presenting with palmoplantar pustules: Comparative analysis of serum IL-22, NETs and IL-8 with usual palmoplantar pustulosis.
    J Dermatol. 2024;51:731-734.
    PubMed     Abstract available


  563. MATSUO M, Niwa H, Koga H, Ishii N, et al
    A case of paraneoplastic pemphigus associated with follicular lymphoma positive only for anti-desmoglein 3 antibody.
    J Dermatol. 2024;51:e164-e165.
    PubMed    


  564. WAKI Y, Nobeyama Y, Chujo S, Asahina A, et al
    Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange.
    J Dermatol. 2024;51:e149-e150.
    PubMed    


  565. WATANABE Y, Nobeyama Y, Asahina A
    A case of postoperative pyoderma gangrenosum on penis caused by patient himself.
    J Dermatol. 2024;51:e154-e155.
    PubMed    


  566. MAENG JE, Son SW, Lee SJ, Kim JC, et al
    Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
    J Dermatol. 2024;51:722-726.
    PubMed     Abstract available


    April 2024
  567. SATO M, Yamamoto T
    Cutaneous manifestations of adult-onset Still's disease: A comparative study between young-onset and elderly-onset groups.
    J Dermatol. 2024 Apr 29. doi: 10.1111/1346-8138.17235.
    PubMed     Abstract available


  568. MINAMI Y, Shinkuma S, Yokoyama T, Shinoda S, et al
    A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
    J Dermatol. 2024 Apr 28. doi: 10.1111/1346-8138.17243.
    PubMed    


  569. HIGASHI Y, Imafuku S, Tsuruta N, Murotani K, et al
    Systemic therapy for psoriasis and the risk of cutaneous infections.
    J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17245.
    PubMed     Abstract available


  570. SONG WJ, Yoon HS
    Impact of residual skin lesions and previous biologic treatment failure on patient-reported outcomes in patients with psoriasis receiving biologic treatment.
    J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17249.
    PubMed     Abstract available


  571. SUGIURA R, Hashimoto T, Ishizuka Y, Okuzawa M, et al
    Matrix metalloproteinase-9 and neutrophil elastase from infiltrating neutrophils with neutrophil extracellular DNA traps in linear IgA bullous dermatosis: A case report.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17244.
    PubMed    


  572. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
    Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
    PubMed     Abstract available


  573. MINAGAWA A, Koga H, Matsunaga K, Hamada A, et al
    Difference in computer-assistance effects on human doctor accuracy in diagnosing acral and non-acral pigmented skin tumors.
    J Dermatol. 2024 Apr 18. doi: 10.1111/1346-8138.17240.
    PubMed    


  574. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    PubMed    


  575. KIM DS, Kim JC, Baek DJ, Kang HY, et al
    Successful repigmentation of hypopigmented scars with micropunch grafting with a skin-seeding technique.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17216.
    PubMed     Abstract available


  576. TAKAHASHI-WATANABE M, Fujimura T, Amagai R, Ohuchi K, et al
    Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17221.
    PubMed     Abstract available


  577. ZHANG L, Jin L, Zhao Y, Cai H, et al
    A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17236.
    PubMed    


  578. TAKAHASHI T, Takahashi T, Ikawa T, Terui H, et al
    Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
    J Dermatol. 2024 Apr 15. doi: 10.1111/1346-8138.17233.
    PubMed     Abstract available


  579. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    PubMed     Abstract available


  580. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    PubMed     Abstract available


  581. HAYAKAWA K, Irisawa R, Umefune R, Mae K, et al
    Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17218.
    PubMed    


  582. SITTIWATTANAWONG P, Kantikosum K, Charoenchaipiyakul K, Pootongkam S, et al
    In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17207.
    PubMed     Abstract available


  583. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    PubMed    


  584. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    PubMed    


  585. UHARA H, Kiyohara Y, Isei T, Nagase K, et al
    Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance.
    J Dermatol. 2024;51:475-483.
    PubMed     Abstract available


  586. LIM S, Sidky L, Eliott E, Cobos G, et al
    A gyrate pattern of discoid lupus erythematosus.
    J Dermatol. 2024;51:e106-e107.
    PubMed    


  587. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
    Dietary habits in adult Japanese patients with vitiligo.
    J Dermatol. 2024;51:491-508.
    PubMed     Abstract available


  588. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    PubMed    


  589. KIM KH, Kwon SH, Sim WY, Lew BL, et al
    Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.
    J Dermatol. 2024;51:552-557.
    PubMed     Abstract available


  590. TSUNEMI Y, Otsuka A, Nonaka Y
    Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
    J Dermatol. 2024;51:526-531.
    PubMed     Abstract available


  591. FAJUYIGBE D, Sewraj P, Connetable S, Molamodi K, et al
    Weekly hair washing: The recommended solution for women with afro-textured hair to alleviate dandruff and scalp discomfort.
    J Dermatol. 2024;51:518-525.
    PubMed     Abstract available


  592. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    PubMed     Abstract available


  593. AO S, Huang G, Tang X, Zhu Z, et al
    Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease.
    J Dermatol. 2024;51:602-606.
    PubMed     Abstract available


  594. SUN X, Zhang J, Yang Q, Lin J, et al
    Treatment of epidermolysis bullosa simplex with dupilumab.
    J Dermatol. 2024;51:e131-e132.
    PubMed    


  595. SAKAMOTO K, Fujihiro M, Sakamoto A, Yamada C, et al
    A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation.
    J Dermatol. 2024;51:e120-e122.
    PubMed    


  596. USUI-TANIGUCHI M, Kawakami Y, Toi Y, Kaji T, et al
    Pruritic folliculitis of pregnancy with granular deposition of immunoglobulin G along the basement membrane zone.
    J Dermatol. 2024;51:e125-e126.
    PubMed    


  597. LEE SG, Kim SC, Kim JH
    Risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
    J Dermatol. 2024;51:597-601.
    PubMed     Abstract available


    March 2024
  598. YOKOTA K, Takenouchi T, Fujisawa Y, Fukushima S, et al
    Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
    J Dermatol. 2024 Mar 26. doi: 10.1111/1346-8138.17002.
    PubMed     Abstract available


  599. IKUMI N, Hayama K, Kitamura N, Terui T, et al
    Higher prevalence of nail psoriasis in patients with psoriatic arthritis receiving biologic therapy: A single center cross sectional study.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17196.
    PubMed    


  600. FUJIMOTO A, Hayashi R, Iguchi S, Abe R, et al
    Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17197.
    PubMed     Abstract available


  601. XIE L, Lopes Almeida Gomes L, Stone CJ, Faden DF, et al
    An update on clinical trials for cutaneous lupus erythematosus.
    J Dermatol. 2024 Mar 15. doi: 10.1111/1346-8138.17161.
    PubMed     Abstract available


  602. TEBOUL A, Arnaud L, Chasset F
    Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17177.
    PubMed     Abstract available


  603. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17186.
    PubMed     Abstract available


  604. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    PubMed    


  605. CHIU YJ, Li CY, Wang TH, Ma H, et al
    Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
    J Dermatol. 2024 Mar 12. doi: 10.1111/1346-8138.17187.
    PubMed     Abstract available


  606. HASEGAWA M, Chasset F, Chong BF, Fiorentino DF, et al
    International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
    J Dermatol. 2024 Mar 7. doi: 10.1111/1346-8138.17153.
    PubMed     Abstract available


  607. TAKADA M, Kikuchi N, Yamamoto T
    Umbilical psoriasis is not relevant to psoriatic arthritis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17189.
    PubMed     Abstract available


  608. TAKAYAMA E, Takai T, Fujimoto M, Yoshioka A, et al
    Bowen disease with sebaceous differentiation arising from clonal seborrheic keratosis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17180.
    PubMed     Abstract available


  609. KITAYAMA S, Katsuumi K, Takatsuka S, Shimizu T, et al
    Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17176.
    PubMed    


  610. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    PubMed     Abstract available


  611. OYA K, Nakamura Y, Shen LT, Ishizuki S, et al
    Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17183.
    PubMed     Abstract available


  612. KIRCHLER CA, Fritz A, Spiegelfeld C, Mullegger RR, et al
    19-month follow-up survey on women with atopic eruption of pregnancy postpartum: An encouraging outlook.
    J Dermatol. 2024;51:467-469.
    PubMed    


  613. ODAWARA M, Mezaki M, Yoshimura T, Takaoka A, et al
    Epidermal turnover and iron metabolism in senile lentigo.
    J Dermatol. 2024;51:453-457.
    PubMed     Abstract available


  614. HE MJ, Wang YJ, Ran DL, Fu DS, et al
    Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study.
    J Dermatol. 2024;51:403-408.
    PubMed     Abstract available


  615. KWON IJ, Kim SE, Kim SC, Lee SE, et al
    Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
    J Dermatol. 2024;51:441-447.
    PubMed     Abstract available


  616. YU DA, Kim SR, Cho SI, Kwon O, et al
    Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.
    J Dermatol. 2024;51:429-440.
    PubMed     Abstract available


  617. RAO L, Yang M, Chen H, Feng YY, et al
    Monkeypox 2023 in China: Dermatologist in the frontline with dermoscopic and reflectance confocal microscopy findings.
    J Dermatol. 2024;51:e81-e82.
    PubMed    


  618. ZHOU Y, Xiao Y, Wang Y, Li W, et al
    Refractory atypical IgA pemphigus successfully treated with apremilast.
    J Dermatol. 2024;51:e86-e87.
    PubMed    


  619. AKASAKA E, Rokunohe D, Nakano H, Yamatani S, et al
    A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763.
    J Dermatol. 2024;51:e74-e76.
    PubMed    


  620. SUGIOKA K, Kondo M, Yamanaka K
    Elephantiasis verrucous lesions on psoriatic plaque improved with anti-IL-23p19 antibody therapy.
    J Dermatol. 2024;51:e77-e78.
    PubMed    


  621. KOBAYASHI A, Terui H, Takahashi T, Mizuashi M, et al
    A case of lymphangiectatic variant of giant pilomatricoma with bullous appearance: evaluation through magnetic resonance imaging.
    J Dermatol. 2024;51:e79-e80.
    PubMed    


  622. TSUJI H, Ichiki N, Niwa H, Iwata H, et al
    Bullous pemphigoid following hand, foot, and mouth disease.
    J Dermatol. 2024;51:e68-e69.
    PubMed    


    February 2024
  623. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    PubMed    


  624. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    PubMed     Abstract available


  625. KAMEDA E, Matsuzawa T, Togawa Y, Hashimoto R, et al
    Amelanotic melanoma in oculocutaneous albinism type 4 detected using violet-light dermoscopy.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17164.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.